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CHAPTER 1. REVIEW OF LITERATURE 
Anatomy of the bovine ta il 
The median caudal ( coccygeal) artery starts at the first caudal vertebrate and 
continues down the length of the tail (Getty, 1975). Th is artery is an extension of the median 
sacral artery which originates from the abdominal aorta. The abdominal aorta is a segment 
from the descending aorta (Scha ller, 1992; Getty, 1975). The median caudal artery is 
s ituated inside a vascu lar grove, which is enclosed by a pair V-shaped bones, ca lled the 
hemoral processes, which originate from the caudal vertebrate (Getty, I 975 ; Dyce et a l. , 
1987). It a lso runs directly ventral and parallel to the median caudal vein. car the middle 
of each caudal vertebra, the median caudal artery branches out to fo rm the ventral and dorsal 
branches (Getty, 1975). 
The median caudal artery is also situated between the median ventral sacrocaudal 
musc les, these are the lateral flexor muscles of the tai l (Evans and Christensen, 1979). These 
ventral median muscles have their highest muscle density at the second vertebra, but virtually 
di sappear by the fourth vertebra. The limbs of animals are primarily comprised of slow-
twitch muscle fibers. It is thought that " the increased occurrence of slow-twitch distally in 
the bovine tail indicates that the muscles are playing an increasing postural ro le at the 
expense of potential for rapid movement" (Young and Kenrick, p. 55, 1989). 
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Architecture of the median caudal artery 
The bovine tail artery has yet to be hi stologically studied. Ashida et al. ( 1988) has 
studied the morphology of the bovine tail artery myocyte using electron microscopy, and this 
will be discussed later. In general , arteries are predominantl y composed of three layers: the 
tunica intima, the tunica media, and the tu nica adventitia. The tunica intima, a sing le layer of 
endothelial cells, lines the inner surface of the vessel lumen. The middle layer (tunica media) 
of the artery is separated from the tunica intima by a layer o f connecti ve tissue ( lamina 
propria). The tunica media is composed o f several layers o f smooth muscle cells oriented 
c ircumferentially or longitudinally. These layers of smooth muscle cells vary in number 
depending on the s ize of the vessel. The outer arterial layer is absent of smooth muscle cell s 
and is called the tunica adventitia. It is composed of collagen fibers that are wrapped around 
the tunica media layer. Axo n varicosities innervate blood vessels along the tunica adventiti a 
layer, and rarely penetrate into the tunica media layer (Ilirst and Edwards, 1989). The 
dens ity of adrenergic innervation and the neuromuscular j unction width d istance isn' t 
homogeneous between tissues and along the length of the vessel ( Furchgott, 1972; N ie ld and 
Zelcer, 1982; Merrill ees et a l. , 1963). The neuromuscular j uncti on w idth for blood vessels is 
usuall y between 50nM to 1 OOnM (Nield and Zelcer, 1982). 
Smooth muscle cell s are characteri sti call y spiral shaped, and have a length and 
d iameter of approximately 40-60µm and 4µm, respecti vely (Hirst and Edwards, 1989). 
However, Ashida et al. ( 1988) found that the myocytes of the bovine tai l artery were unique. 
They were spindle shaped and had a length greater than 125- I SO~Lm, and a diam eter of 10-
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15µm. Smooth muscle cells also possess a nucleus, mitochondria, and sarcoplasmic 
reticulum (Hirst and Edwards, 1989). The bovine tail artery myocytes contain very few 
mitochondria, which are located near the plasma membrane and nucleus (Ashida et al., 1988). 
The sarcoplasmic reticulum was also sparse, and was concentrated just under the plasma 
membrane. In fact, Ash ida et al. ( 1988) found that the bovine tail artery myocyte has 60% 
less sarcoplasmic reticulum than the rat thoracic artery. Consequently, the sarcoplasmic 
reti culum has only a minor role in the regulati on of the intracellular calcium concentration. 
The rise in the intracellular calcium concentration was primarily due to the inOux of 
extracellular ca lcium, which Ashida et al. ( 1988) associated with gated calcium channels . 
Ashida and Blaustein (1987) also observed that when the intracellular calcium concentration 
exceeded the amount needed for a contraction, the efflux of excess calcium (80-90%) was 
mediated by the sod ium-calcium exchanger (located in the plasma membrane), not the 
sarcolemma calcium pump. This contrasts wi th results from the rat aorta, where the ATP-
driven calcium pump was found to be more important than the sodium-calcium exchanger 
(Ashida and Blaustein, 1987). 
Mediators of vasoactivity 
Contractility of arterial smooth muscle is predominantly regulated by the sympathetic 
nervous system, and by hormones synthesized and released into the bloodstream by the 
adrenal gland. The three major hormones synthesized by the medulla of the adrena l gland are 
norepinephrine (NE), epinephrine, and dopamine. A bioassay of the bovine adrena l medulla 
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indicated that epinephrine, NE, and dopamine are synthesized in the following amounts 4000, 
1250, and 17 (expressed as µg/g tissue), respecti vely; these amounts constituted 76%, 23%, 
and 1 % of the total (Holzhauer and Sharman, 1972). While the adrenal g land can re lease 
epinephrine, NE, and dopamine into the bloodstream, onl y NE is released by the 
prejunctional sympathetic neuron. 
The biosynthesis of N E and epinephrine follow identical pathways, starting with the 
precursor, tyrosine. T he rate-limiting enzyme, tyrosine hydroxylase, converts tyrosine to 3,4-
dihydroxyphenylalanine (DOPA). DOPA is then converted to dopamine by dopa-
decarboxylase. D opamine is oxidized by dopamine-p-hydroxylase to NE. 
Phenylethanolamine-N-methyltransferase in the adrenal gland is responsible fo r the 
conversion of NE to e pinephrine. Catecholamine synthesis, within the nerve termina l, 
primarily occurs in the varicosities of the prejunctional nerve terminal. However, the 
conversion of dopamine to NE occurs in conjunction with storage ves icles located in the 
nerve terminal. Norepinephrine is stored within these vesicles and quantally released when 
the nerve is stimulated (Katzung, 1992; Euler, 1972). 
The vascular endothe lium (tunica intima) is important in the regulation of smooth 
muscle tone. The endothelium has been reported to depress the contractility o f blood vessels 
to catecho lamines (Oriowo et al., 1987; Doggrell , 1992; Macl ean et al ., 1993; Kaneko and 
Sunano, I 993). This suggests that the endothe lium has a vasore laxant effect on vessels. 
Endothelium-derived relaxing factor (EDRF), now thought to be primarily nitric oxide (NO), 
is re leased from the vascular endothelium and mediates the vasodil ati on (Ignarro et al., 1987; 
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Palmer et al. , 1987). Results have demonstrated that removal of the endothe lium enhances 
the contractil ity of blood vessels to a similar magnitude as inhibiting the synthesis of 0 
(MacLean et al., 1993; Vo et al., 1992). Coincidental ly, Palmer et al. ( 1987) suggested that 
NO and EDRF are identical compounds. Ignarro et al. ( 1988) later proved, in the bovine 
intrapulmonary artery, that NO was responsible for the vascular relaxation induced by EDRF. 
N itric oxide mediates the vasorelaxant effect of endothelium-dependent vasodilators, like 
bradykinin, prostaglandin 0 2, and acetylchol ine (Tgnarro ct al. , 1988; Fisher-Nakielski and 
Schror, 1990; Braun and Schror, 1992; Ayaj iki et al. , 1993). 
Nitric ox ide is released spontaneously (basal release) by blood vessels, such as the 
bovine coronary artery (Purdy and Milburn, 1991 ). Vo et al.( 1992) suggested that NO is 
released from endothelia l cells to oppose endothelia l shear stress, thereby limiting blood 
vessel damage during vasoconstriction . Endothelial shear stress is caused by an increase in 
vascular tone, thereby changing the blood flow velocity (Vo et al.. 1992). Activation of a 1-
and aradrenoceptors may also mediate the synthesis and release of NO (Kaneko and 
Sunano, 1993 ; MacLean et al. , 1993). The amount of NO released from the endothelium 
appears to be directly proportional to the magnitude of the smooth muscle contraction, and 
occurs without any change in the membrane potential of the endotheli al cell (Vo et al. , 1992; 
Komori et a l. , 1988). Bradykinin, a vasodepressor, also releases NO in a concentration-
dependent manner (Palmer et al., 1987). These results indicate that 0 contri butes to the 
maintenance of vessel tone. 
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Catecholamine disposition mechanisms 
Norepinephrine is predominantly stored in synaptic vesicles within the prejunctional 
nerve terminal. Following sympathetic nerve stimulation, NE is quantally exocytosed and 
released into the neuromuscular junction. The released NE is then able to bind to 
prejunctional aradrenoceptors which inhibit the release of NE, or diffuse across the 
junctional cleft to react with postj unctional a-adrenoceptors (Hirst and Edwards, 1989). The 
concentration of catecholamines in the neuroeffector junction, whether originating from the 
sympathetic neuron or bloodstream, is controlled by several disposition mechanisms. Within 
the junctional cleft NE can either be inactivated by catechol-0-methyltransferase (COMT) 
found within the plasma, or diffuse out of the synapse into the circulation (Coquil et al., 
1973; Trendelenburg, 1972). The remaining NE, within the neuroeffector junction, can be 
actively taken back into the prej unctional nerve terminal by uptake 1 (neuronal uptake), or be 
taken up by the effector tissue by uptake2 (extraneuronal uptake). Upon uptake into the nerve 
terminal or effector cell, NE undergoes enzymatic inactivation by COMT and by monoamine 
oxidase (MAO) (Levin and Furchgott, 1970; Trendelenburg, 1972; Verity et al., 1972). 
Uptake 1 is a saturable carrier-mediated transport system for catecholamines, and is 
located along the medial-adventitial border (site of adrenergic innervation) of the artery 
(Trendelenburg, 1990; Levin and Furchgott, 1970). Therefore, catecholamines circulating in 
the bloodstream need to diffuse across the tunica media layer of the artery to reach uptake 1 
(de la Lande, 1989; Morris et al., 1988). Uptake 1 also acts by "facilitated exchange 
diffusion" to indirectly mediate the release of NE from the prejunctional nerve terminal 
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(Trendelenburg, p. 15, 1990). "Facilitated exchange diffusion," predominantly associated 
with indirectly acting sympathomimetic amines like tyraminc and guanethidine, occurs when 
substrates for uptake, are also substrates for the vesicular uptake mechanism associated with 
storage vesicles located within the prcjunctional nerve terminals (Trendelenburg, p. 15, 1990; 
Miyahara and Suzuki, 1985). These indirectly acting amines are taken up into the nerve 
terminals by uptake1, and if not deaminated by MAO, act to displace NE fro m the storage 
vesicles (Miyahara and Suzuki, 1985; Furchgott et al., 1963). 
Uptake2 is a carrier-mediated transport system that favo rs the inward transport of 
positively charged protonated substrates (Schomig et al. , 1992). It is primarily fo und within 
the tunica media smooth muscle layer of the artery (de la Lande, 1989; Morris et a l. , 1988). 
High concentrations o f catecho lamines are able to saturate this uptake mechanism (Schomig 
and Schonfeld, 1990). The membrane potential o f the effector cell provides the driving fo rce 
for uptake2. The inside negativity of the cell faci litates uptake and hinders the efnux of 
substrates. Therefore, depolarization of the effector cell prevents substrate uptake and causes 
the outward efflux of substrates (Schomig ct a l. , 1992). Pharmaco logical inhibitors fo r 
uptake2 are able to impair both the infl ux and efflux of catecholamines within the e ffector 
cell (Eckert et al. , 1976). 
Catecho lamines undergo deamination by MAO. Monoamine oxidase is a 
mi tochondrial enzyme located in both the adrenergic nerve terminal and the effector cell 
(Coquil et al. , 1973 ; Verity et al., 1972; Levin and Furchgott , 1970). Monoamine oxidase 
ex ists in two forms: type A and type B. Type A is found within sympathetic nerve terminals, 
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brain, and liver, while type B has been found in the arterial walls of rats and in the rabbit 
aorta (Coquil et al., 1973). Norepinephrine and serotonin are primarily metabolized by type 
A MAO (Rivett et al., 1982; Precious and Lyles, 1988). Type B metabolizes NE to a lesser 
degree than type A. Tyramine is a good substrate for both MAO types (Caramona, 1982; 
Precious and Lyles, 1988). Trendelenburg et al. (1987) found that the Km for MAO in the 
nerve terminal is higher than the Km for uptake 1• Therefore, MAO is not saturated by the 
activity of uptake1• 
Catechol-0 -methyltransferase (COMT) is primarily found within the tunica media 
layer of blood vessels, and is responsible for the 0-methy lation of catecholamines (Verity et 
al., 1972; Levin and Furchgott, 1970). The activity of COMT is dependent on the influx of 
catecholamines through the uptake2 mechanism (Martel et al. , 1993; Graefe and 
Trendelenburg, 1974). This enzyme can be saturated at high concentrations of 
catecholamines since its Km is lower than that of uptake2 (Henseling, 1980). When COMT is 
saturated, the excess catecholamines in the effector tissue are transported back out of the 
tissue through uptake2, thereby maintaining a steady-state balance between the uptake of 
catecholamines and the rate of COMT activity (Eckert et al., 1976). Within the effector cell , 
COMT is more important than MAO in catecholamine metabolism (Eckert et al. , 1976; 
Henseling, 1980; Kalsner and Nickerson, 1969; Schomig et al., 1992). This is partially 
because COMT and MAO function is series. Since MAO is a mitochondrial enzyme and 
COMT is predominantly located in the cytosol, it can be hypothesized that once 
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catecholamines are taken up by uptake2, they are first exposed to COMT before they can 
reach the mitochondria fo r inactivation (Ka lsner and N ickerson, 1969). 
The catecholamine concentration in contact with the various disposition mechanisms 
is determined by the thickness of the tissue, the width of the neuromuscular junction, and the 
density of adrenergic innervation (Trcnde lenburg, 1972). Catecholamines, circulating in the 
bloodstream, have a higher concentration within the lumen of the artery (intima layer) than at 
the adventitia layer (de la Lande, 1989). These catecholamines diffuse across the three layers 
of the artery (inti ma, media, and adventitia) as determined by these catecho lamine 
concentration gradients found across the arterial wall. However, in large arteries, the 
vasovasorum and lymph may contribute to maintaining the catecholamine concentration in 
the adventitial layer s imilar to that in the lumen. The media layer has the lowest diffusion 
coefficient, therefore making it a major obstacle for amine diffusion. This suggests that the 
rate of catecholamine uptake, by uptake 1 or uptake2, is linked to the abil ity of the amine to 
diffuse across the arterial layers (de la Lande, 1989). The concentration of catecholamines 
within the neuromuscular junction is inversely proportiona l to the di stance between the nerve 
terminal and effector tissue (width of the neuromuscular junction). As the w idth of the 
neuroeffector junction increases, the neuronally released catecholamines have to traverse a 
larger distance to reach the effector ti ssue. Therefore, the potentia l for the amines to diffuse 
away from the synapse into the c irculation increases. The activity of uptake1 is dependent on 
the distance between the nerve terminal and the effector tissue. As the d istance increases, the 
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importance of uptake1 in disposing catecholamines decreases. This was demonstrated on the 
inferior and medial muscles of the cat nictitating membrane (Trendelenburg, 1972). 
The density o f adrenergic innervation (therefore uptake1) also regulates the amount of 
NE exposed to the e ffector disposition mechanisms (Schomig et al., 1992; Morris et al. , 
1988; Burnstock et al., 1972; Gaefe and Trendelenburg. 1974). This was confirmed in the cat 
nictitating membrane (Graefe and Trendc lenburg, 1974). I lydrocorti sone, an uptake2 
inhibitor, fai led to potentiate the catecholami ne response in the cat nictitating membrane. 
However, after the nictitating membrane was denervated, hydrocorti sone potentiated the NE 
response. This suggested that the high activity of uptake 1 in the ni cti tating membrane had 
significantl y decreased the E concentration within the neuroeffector j unction. Therefore, 
the s ignificance of uptake2 in the inacti vation of NE was not apparent until the ti ssue was 
denervated (Graefe and Trendelenburg, 1974). Wyse (1974), in his studies on rabbit aortic 
strips, estimated that 50% of exogenously administered NE and 90% of neuronally released 
NE was taken up by uptake1• S ince the rabbit aorta is not well innervated, it is hypothesized 
that the importance of uptake 1 increases in more highly innervated ti ssues, while the acti vity 
o f uptake2 decreases (Burnstock et al., 1972; Wyse, 1974; Graefe and Trendelenburg, 1974). 
chomig et a l. ( 1992) demonstrated that there was more accumulation of 3[H] Eat the 
surface (uptake1) o f the more highly innervated rat vas deferens than in the rat atrium. 
Coinc identally, there was also a greater percentage of [3H]NE in the center of the musc le 
(uptake2) of the less densely innervated rat atrium than in the rat vas deferens. They 
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concluded that uptakc2 has only a minor role in the removal of [31 !]NE from the j unctional 
cleft due to the high density of adrenergic innervation o f the rat vas deferens. 
The physiologica l role played by each catecholamine di sposi tion mechanism has been 
ascertained using pharmaco logical inhibitors for the specific mechanism. The importance of 
each inhibited disposition mechanism is assessed by its abi lity to prolong and/or potentiate 
the response to catecholamines (Trendelenburg, 1972). Cocaine and corticosterone have 
been extensively used to block uptakc1 and uptake2, respecti vely (Furchgott and Garcia, 
1968; Furchgott et al., 1963; Wyse, 1974). The enzymatic mechan isms, MAO and COMT, 
have been studied using the inhibitors, iproniazid and tropolone, respectively (Furchgott and 
Garcia. 1968; Wyse, 1974). 
Pharmacologica l differentiation of adrenoccptors 
The catecholamines, NE and epinephrine, mediate their bio logical response by 
binding to receptors located on either the prejunctional or postjunctional cell membrane 
(Ruffolo, 1991 ). These receptors were classified by Ahlquist (1948) into two groups, a - and 
P-adrenoceptors, based on the relati ve potency of several agonists to initiate opposing 
responses (excitatory or inhibitory). Lands et al. ( 1967) further subdivided the P-
adrenoceptors into P1- and Pradrenoceptors. The a-adrenoceptors were a lso divided into 
two groups, a 1- and aradrenoceptors, by Langer ( 1974). Adrenoceptors can be 
pharmacologically characterized by comparing the e ffective concentration of an 
agonist/antagonist to produce a response (relative potency of a drug). However, using 
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agonists to classify receptor types can be difficult since the response to the agonist is 
determined by the receptor's efficacy and affinity for the agonist. Therefore, receptors with a 
high affinity for the agonist, but having a low efficacy, may generate a low response or 
possibly no response at all (Drew, 1985). The predominant property governing the receptor's 
response to the antagonist, however, is affinity. Therefore, tissues having identical receptors 
for an agonist should yield relatively identical responses in the presence of a selective 
antagonist for the receptor (Drew, 1985; Arun lakshana and Schi ld, 1959). Receptors can a lso 
be purified and characterized by ligand-binding. This method also utilizes the affinity of a 
receptor for a particular antagonist (McGrath, 1983). Unfortunately, agonists and antagonists 
tend to lose their specificity fo r a specific adrenoceptor at high concentrations. 
The agonists, NE and epinephrine, have approx imately equal potencies at both a 1-
and aradrenoceptors, as does the antagonist, phentolamine. It is speculated, however, that 
aradrenoceptors have a lower threshold for NE than a 1-adrenoceptors (McGrath, 1983; 
Drew and Whiting, 1979). Phenylephrine and cirazoline are selective a 1-agonists, while 
prazosin and WB4101 are selective a 1-antagonists (Wilson et al., 1991 ). The order of 
potency of some selective aragonists are: medetomidine > clonidine = B-HT 920 > 
xylazine (Virtanen et al., 1988; Wilson et al., 1991 ). The selectivity of some common a 2-
antagonists are idazoxan > rauwolscine > yohimbine (Wilson et al., 1991). Some selective a -
adrenoceptor antagonists have a wide potency range, therefore, Medgett and Langer (1984) 
suggested that selective antagonists must be used over a 100-fold concentration range when 
characterizing receptors by Schild plot analysis. The selective a 1-adrenoceptor antagonist, 
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prazosin, has a selectivity for a 1-adrenoceptors, over a radrenoceptors, that spans over a 100-
fo ld concentration range. Coincidentall y, the selecti ve aradrenoceptor antagonist, 
yohimbine, has a selectivity for aradrcnoceptors, over a 1-ad renoceptors, that a lso covers a 
I 00-fold concentration range. a 1-Adrenoceptors are commonly classified as having a 
prazosin/yohimbine ratio of 100, while a 2-adrenoceptors have a yohimbine/prazosin ratio of 
I 00 (Drew, 1985). 
The potency order for P-adrenoceptors was defined by Furchgott ( 1972): 
isoproterenol > epinephrine > NE > phenylephrine. p
1
-Adrcnoceptors have an equal affi ni ty 
fo r both epinephrine and NE, whi le p
2
-adrenoceptors have a greater affinity for epinephrine 
than E (Ruffo lo, 1991 ). lsoproterenol has a greater affini ty fo r P2-adrenoceptors than P1-
adrenoceptors. Activation of Pr adrenoceptors, by isoproterenol, also activates adenylyl 
cyclase to a greater degree than P1-adrenoceptors (Green et al. , 1992). 
Characterization of a-adrenoccptors 
Langer ( 1974) suggested that the a-adrenoceptors, as proposed by Ahlqu ist, were not 
a homogeneous population, and that they be di vided into two subtypes (a1 and a 2) based on 
their respecti ve anatomical differences. I le suggested that a 1-adrenoceptors are located 
postjunctionally, and aradrenoceptors are located prejunctiona lly. Berthelsen and Pettinger 
( 1977) later redefined Langer's definiti on based on a functional approach. They defined a 1-
adrenoceptors as postjunctional receptors that mediate exc itatory responses. The 
prejunctional receptors responsible fo r inhibiting the neuronal release of NE were then 
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classified as cx.2-adrenoceptors (McGrath, 1983; Berthelsen and Pettinger, 1977). This 
functional classification was later disproved by Drew and Whiting ( 1979) who found 
postjunctional excitatory cx. 1- and cx.radrenoceptors. These results suggest that cx. 1-
adrenoceptors are located postjunctionally and mediate an excitatory response. Activation of 
cx.radrenoceptors causes both an inhibitory and excitatory effect at the pre- and postjunctional 
cell membrane, respecti vely, in smooth muscle. 
There does appear to be a difference in the vascular distribution of cx. 1- and cx.2-
adrcnoceptors based on their relative distance from the nerve terminals. cx. 1-Adrenoceptors 
are primarily located along the adventitial-medial border, in close proximity to the 
sympathetic innervation of the artery. Therefore, released NE from the nerve terminals 
preferentially acts at cx. 1-adrenoceptors. cx.2-Adrenoceptors are located farther away 
(extrajunctionally) from the nerve terminals near the intimal layer of the artery. It is 
hypothes ized that cx.radrenoceptors are predominantly stimulated by circulating epinephrine 
in the bloodstream (McGrath, 1983; Langer and Shepperson, 1982). This distribution of cx.-
adrenoceptors has been demonstrated in the hind I imb of the dog by Langer et al., ( 1980). 
However, Langer ct al. , ( 1980) also hypothesized that an additional cx. 1-adrenoceptor 
population resides cxtrajunctionally in conjunction with the population of cx.radrenoccptors. 
Medgett and Langer ( 1986) using the rat tai l artery, demonstrated that cx. 1- and ar 
adrenoceptors are both located extrajunctionally and in close proximity to the nerve 
terminals. These results suggest that cx.2-adrenoceptors are distributed unevenly in blood 
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vesse ls, with their greatest density occurring near the vessel lumen (Medgett and Langer, 
1986). 
The distribution of a 1- and aradrenoceptors is not homogeneous within tissues 
(Medgett and Langer, 1984; Atkinson et a l., 1988). The rat vas deferens and rabbit urethra 
have a higher population of functional postjunctional aradrenoceptors than a 1-
adrenoceptors, while the reverse is true for the bovine oviductal arteries, rat anococcygeus 
muscle, and rat tail artery (Andersson et al., 1984; Drew and Whiting, 1979; Atkinson et al., 
1988; Costa et al., 1992). Whether a homogeneous population of a-adrenoceptors exists in 
the peripheral vessels of the bovine is uncertain . Nevertheless, studies have indicated that 
NE has a high potency for a-adrenoceptors in the isolated bovine tail artery (Ashida et al., 
1988) and iso lated bovine dorsal pedal vein (Solomons et al., 1989). The isolated perfused 
bovine ear artery also elicits a sign ificant pressor response when exposed to phenylephrine 
(Eghianruwa and Eyre, 1991 ). 
There appears to be an inverse relationship in the a-adrenoceptor population along the 
length of the vessel. The density of a 1-adrenoceptors appears to predominate in the proximal 
part of the rat tail , while the density of a 2-adrenoceptors increases in the distal end (Medgett 
and Rajanayagam, 1984; Medgett, 1985; Rajanayagam and Medgett, 1987). There is some 
speculation that a 2-adrenoceptors are predominantly located in the smaller resistance vessels 
(Langer and Shepperson, 1982). 
This lack of homogeneity for a-adrenoceptors makes identification of postjunctional 
aradrenoceptors difficult (Medgett and Langer, 1984). Identification of aradrenoceptors 
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has been conclusively demonstrated using pressor responses in vivo (Langer and Shepperson, 
1982; Langer et al., 1980). However, identification of arterial a 2-adrenoceptors in vitro with 
selective agonists and antagonists has been controversial (Savino and Varela, 1991; Atkinson 
et al., 1988; Dunn et al., 199 1 ). Dunn et al. ( 1991 ), using the isolated rabbit distal saphenous 
artery, suggested that a complex interaction occurs between postjunctional a 1- and <Xr 
adrenoceptors. Therefore, expression of aradrenoceptors is dependent on the prior 
simulation of a 1-adrenoceptors. It has been speculated that increasing the tone of the vessel, 
similar to physiological conditions in vivo, helps to uncover postjunctional aradrenoceptors. 
Angiotensin II and vasopressin have been used to potentiate the response of an a 2-agonist on 
the isolated rat tail artery (Templeton et al., 1989). However, angiotensin II did not always 
potentiate the response of an aragonist on the isolated rat tail artery (Savino and Varela, 
1991). 
a 1- and a 2-Adrenoceptors utilize different second messenger pathways to mediate 
their contractile response. The contractions can either be phasic (response has a short 
duration) or tonic (response is prolonged and maintained) (Ford, 1995). a 1-Adrenoceptors 
are capable of mediating both phasic and tonic contractions. They mediate their effects by 
stimulating the phosphatidylinositol second messenger system. When activated, the a 1-
adrenoceptor couples to a G-protein (Gp). This protein complex stimulates phospholipase C, 
thus catalyzing the hydrolysis of inositol-4,5-bisphosphate into inositol-1,4,5-triphosphate 
(IP3) and diacylglycerol (DAG). IP3 mediates the release of calcium from the sacroplasmic 
reticulum to induce aphasic contraction. DAG activates protein kinase C (PKC) to initiate a 
17 
tonic contraction. Once PKC is activated it phosphorylates proteins fo und along the actin 
fi lament of the smooth muscle cell , thus initiating a contraction. Protein kinase C also 
mediates the opening of potential-sensitive calcium channels to cause an influx of 
extracellular calcium (Wilson et al., 1992; Ford, 1995). This influx of extracelluar calcium is 
responsible fo r maintaining the ton ic contractions. arAdrenoceptors mediate their response 
by coupling to a G-protein (Gi). This protein complex inhibits adenylyl cyclase, thereby 
decreasing the cytosolic accumulation of cAMP. This resul ts in an influx of extracelluar 
calcium through potential-sensitive channels to cause a pro longed tonic contraction (Ford , 
1995; Ruffo lo et a l., 1991; Wilson et al., 1991). Ashida et a l. (1988) demonstrated that 85% 
of the NE-induced contraction in the myocyte of the bovine tai l artery was mediated by the 
influx of extracellular calcium, while only 15% was due to calcium mobilization from the 
sarcoplasmic reticulum. In the rat aorta, each mechanism was capable of generating 50% of 
the contraction induced by NE. 
It has been well established that both a 1- and aradrenoceptors, as originally 
proposed by Langer (1974), can be further subdivided into distinct subtypes. Investigators 
have proposed several classification schemes for the identification of a 1-adrenoceptor 
subtypes. The discrepancy between classifi cation schemes and nomenclature is dependent on 
the techniques (functional contractions, radioligand binding, and molecular biology) and a 1-
adrenoceptor antagonists used when differentiating between subtypes (Hieble et al., 1995). 
Recently ( 1995), the International Union of Pharmacology Subcommitte on Nomenclature 
for Adrenoceptors proposed that a 1-adrenoceptors can be clearly divided into the three 
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subtypes: a 1A, a 18, and alD. A functional response, using se lective a 1-adrenoceptor 
antagonists for each subtype, has been clearly attributed to each subtype. There are fewer 
uncertainties concerning the subclassification or aradrenoceptors than the a 1-adrenoceptors. 
a 2-Adrcnoccptors have been pharmacologicall y classified into four subtypes (a2A, a 20, 
a 2c,and a 20) using iso lated cell lines and radioligand binding techniques (Bylund, 1992). 
a 1-Adrenoceptors have been found to possess two binding sites that have either a high 
or low affinity for agonists/antagonists (Colucci ct al., 1985; Morrow and Creese, 1986; 
Jagadecsh and Deth, 1987; Minneman, 1988). Epinephrine di splacement studies for the 
[3H]Prazosi n binding s ite have revealed both high and low affin ity binding sites in the bovine 
aorta from young animals (Jagadeesh and Deth, 1987; Jagadeesh et al., 1990). However, 
Jagadeesh et a l. ( 1990) found that the high affinity a 1-ad renoceptor binding site d isappears as 
an animal matures. Therefore, the a 1-adrenoceptors in the adult bovine were dominated by 
the low affi ni ty binding site (Jagadeesh et al , 1990). The low affinity s ite comprised 77% of 
the a 1-binding sites on the bovine thoracic aorta from young anjmals (Jagadeesh and Deth, 
1987). Jagadecsh and Deth (1987) proposed that these two binding sites utilize different 
second messenger pathways for initiating the biological response. When an agonist binds to 
an a 1-adrenoceptor, GDP is dislocated by GTP from the G-protein subunit. The high affi ni ty 
site binds GDP tightly, and is inhibited by the binding o rGTP to the G-protein subunit. 
However, the low affinity site does not bind GDP as ti ghtl y as the high affinity si te, and is 
not affected by GTP-binding. Therefore when the GTP concentration is low, GDP is not 
highly di splaced by GTP from the G-protein subunit o r the high affinity site. As the 
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concentration of GTP increases within a cell , the high affinity site is capable of shifting to the 
low a ffinity site due to the additional bind ing o f GTP to the G-protein subun it, thereby 
destab iliz ing the prote in complex. This uncouples the a. 1-ad renoceptor from the G-protein, 
therefore changing the second messenger cascade (Jagadeesh and Deth, 1987; Jagadeesh et 
a l. , 1990). Jagadeesh and Deth ( 1987), and Jagadccsh ct al. ( 1990), proposed that the low 
affinity s ite is also less efficient than the high affinity s ite in mediating its biological 
response. 
Characterization of P-adrcnoccptors 
Lands et a l. ( 1967) refined the original c lassification of P-ad renoceptors, as proposed 
by A hlquist, by suggesti ng the existence of two types of P-ad renoceptors based on func ti onal 
d iffere nces. They defined P1-adrenoceptors as those mediati ng lipo lysis and myocardial 
contractility, while Pr adrenoceptors were classified as causing bronchod ilation and 
vasorelaxation. P1-Adrenoceptors are located in the cardiac muscle, while Pradrenoceptors 
arc predominantl y located in blood vessels and other smooth muscle. However, the 
epicard ial arteries of the heart are capable of possess ing either subtype, depending on the 
animal species. The bovine descending coronary artery possesses a homogeneous population 
of P 1-adrenoceptors (Purdy and Stupecky, 1986). Pr Adrenoceptors have been characteri zed 
in rat adipose ti ssue by Tan and Curti s-Prior ( 1983). They are also present in the canine 
cutaneous vasculature, and induce vasod ilation (Berl an ct al. , 1994). 
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When activa ted by a ligand, P-adrenoceptors mediate their effects by coupl ing to the 
G-protein, Gs. This protein complex then stimulates adcnylyl cyclase to increase the 
intracellular cAM P concentration (Green et al. , 1992). Green et a l. , ( 1992) demonstrated that 
the P-subtypes have a difference in the ir coupling efficiency. At low epinephrine 
concentrations P2-adrenoceptors acti vate adenylyl cyclase lo a greater degree, and a lso have a 
greater coupling efficiency to the Gs prote in, than P1-adrenoceptors. 
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CHAPTER 2. ST A TEMENT OF THE PROBLEM 
Little knowledge exists about the physiologic/pharmacologic factors which regulate 
the vasoactivity or blood vessels in the bovine. To remedy thi s lack o f knowledge about the 
physiology/pharmacology of the bovine vasculature. we wanted to develop the isolated 
median caudal artery preparation as a model for the study of bovine blood vessels. The 
median caudal artery preparation is an attractive model to use s ince the bovine ta il is readily 
available at slaughter plants. Previously, investigators have primarily used the fo llowing 
isolated vessel preparations in the study o f the bovine vasculature: the coronary artery, the 
cerebral artery, the uterine artery, and the pul monary artery and vei n (Purdy and tupecky, 
1986; Foy et al ., 1992; Ayajiki et al., 1993 ; Suzuki et a l., 1984; Dyer, 1993; Ford ct a l., 1992 ; 
Cai et al., 1994 ; Ignar ro et a l. , 1988) . 
The purpose of thi s study was to determine the characteristics of thi s artery based on 
the fo llowing studies: 
1.) To ascerta in the importance of the catecholamine dispos ition mechanisms using 
inhibitors for uptake 1, uptake2, monoamine ox idase (MAO), and catechol-0-
methyltransferase (COMT). 
2 .) To ascerta in the importance of the endothelium in regulating vasoacti vity . 
3.) To pharmaco logically determine the functionality of a 1- , a 2- , and, Pradrenoceptors 
based on their affinity fo r selective agonists and antagonists . 
4.) To determine the a -adrenoceptor receptor reserve and dissociati on constant fo r NE. 
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CHAPTER 3. MATERIALS AND METHODS 
T issue preparation 
Adult bovine tails were collected at a local abattoir and transported on ice back to the 
laboratory within 120 minutes a fter s laughter. The median caudal artery was dissected out of 
the proximal-medial part of the tai l and c leared of extraneous connecti ve tissue. The tissue 
was kept in a modified Krebs' solution with the fo llowing composition (mM): NaCl, 11 5.2 1; 
KCI, 4.70; CaCl2, 1.80; MgS0 4, 1.16; KH2P0 4, 1. 18; NaHC03, 22. 14; dextrose, 7.88; and 
0.03mM EDT A. Arteries were cut into ring segments 4mm in length. Through each lumen 2 
triangular stainless steel wires were then inserted. The triangular wires were suspended by 
threads in a I Oml iso lated ti ssue bath. One thread was looped under a stationary support near 
the bottom of the bath, while the other thread was connected to a Grass FT-03 force 
transducer. T issue baths, containing Krebs' solution, were maintained at 37°C and aerated 
wi th a 95% 0 2 - 5% C02 mixture. Tissue responses were recorded isometrica lly by a Grass 
or Beckman polygraph (model 7 or model R6 I I, respectively). Ring segments were initially 
stretched to a tens ion of 10- 12 grams (g) and then allowed to relax to a tension of 3g over a 
period of 60 minutes. T issues were then equilibrated at a baseline tension of 2g for at least 
30 minutes. Krebs' so lution was replaced every 20 minutes unless otherwise indicated . For 
each experimental trial , adjacent rings from the same arterial segment were used. 
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Generation of concentration response-curves 
In experiments to evaluate the effect of endothelium removal and L-NAME on the 
E response and to determine the dissociation constant for NE and several antagonists, a ll 
arteries were treated with inhibitors for MAO, COMT, uptake" and uptake2. During the 90 
minute equilibration period all arteries were incubated with the MAO inhibitor, iproniazid 
(0.36mM), for 60 minutes and washed every I 0 minutes over a 40 minute period. Before 
generating a concentration-response relationship to an agonist, the arteries were equilibrated 
with cocaine (3µM), corticosterone ( 1 O~tM) , and tropolonc ( I O~tM) for 20 minutes to block 
uptakel> uptake2 , and COMT, respecti vely. l f cocaine induced a contraction above base line 
(2g tension), the experiment was discarded. 
Administration of each agonist concentration was done cumulatively in 
approximate ly half-log increments. The response to each concentration was allowed to reach 
its maximum before the next concentration was added to the bath. The contractile response 
of each individual agonist concentration was then plotted. Data measurements were obtained 
at the effective agonist concentration required to elicit 50% of its max imal response (EC50) , 
as indicated by Schi ld ( 1949). In experiments that evaluated inh ibitors for the catecholamine 
disposition mechanisms and the dissociation constants for NE and several a -adrenoccptor 
antagonists, a concentration-response curve was generated (and measured) in the absence 
(EC50) and presence (EC50*) of the inhibitor/antagonist under evaluation. The concentration 
ratio (CR) of the agonist EC 50*/EC50 was determined (Furchgott, 1972). 
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Adjusting for en itivity changes 
Any time-dependent shift of the agonist concentration-response relationship during 
the course of an experiment was monitored as recommended by Furchgott (l 972), and as 
used in our laboratory (Zhang and Dyer, 1990). A "time control tissue," which was not 
treated with the drug under evaluation, was paired with each experiment. The concentration 
ratio (CRT) for any time-dependent shift of the agonist concentration-response relationship 
(EC50 at time t /EC50 at time 0) was determined from the two control agonist concentration-
response curves. The concentration ratio (CR) obtained for tissues treated with inhibitors and 
antagonists for the di sposition mechanisms and adrenoceptors, respectively, were adjusted 
according to the formula: CR=CRJCRT. 
Evaluation of the norcpincphrine disposition mechanisms 
Factors regulating the NE concentration at the receptor site were evaluated by the 
ability of each enzymatic and uptake inhibitor to shift the concentration-response curve to the 
left. The disposition mechanisms for both fresh and co ld stored (24 hrs.) ti ssues were 
evaluated. 
Two enzymatic processes for catecholamine inactivation are monoamine oxidase 
(MAO) and catechol-0-methyltransferase (COMT). Iproniazid (0.36mM) was used to 
inactivate MAO, and tropolone ( I 0- 1 OOµM) was used to block COMT. To ascertain the 
importance of neuronal uptake 1, cocaine ( 1- IOOµM) and desipramine (O.J nM-I OµM) were 
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used. Corticosterone 2 1-acetate (0. 1- 1 OOµM), an extraneuronal uptake2 inhibitor, was 
evaluated as we ll as its solvent, ethano l ( 10µ1). 
The equilibrated tissues were initially primed with I OµM NE for l 0 minutes and then 
washed until they relaxed to baseline. Ring segments were then allowed to stabilize at 
baseline for 30 minutes. A control NE concentration-response re lationship was generated 
and the tissues washed until they relaxed to baseline. Each concentration of corti costerone, 
ethano l, cocaine, desipramine, and tropolone was allowed to equilibrate with one ring o f the 
artery segment for 30 minutes. Iproniazid was allowed to equilibrate with an arteria l ring for 
60 minutes, and then the tissue was washed every l 0 minutes over a 40 minute period. This 
was fo llowed by the determination of a second NE concentration-response relationship on all 
ring segments . 
The data analysis for the ab ility of each inhibitor to shift the NE concentration-
response curve to the left was evaluated at the EC50 of the NE concentration-response curve 
before (EC50) and after (EC50*) equili bration with the inhibitor. After correcting fo r 
sensitivity changes over time, a potentiation facto r (PF) was calcu lated using the equati.on: 
PF = (EC50) / ( ECso*). 
The control NE concentration-response curves (0.0 1- 1 OµM) were also analyzed based 
on the sex of the animals. Concentration-response curves to NE, for males and females, were 
analyzed at the EC 50 and maximum response. 
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Evaluation of the response to tyramine 
During equ ilibration, fo ur ring segments were incubated with 0.36mM iproniazid for 
60 minutes and then washed every I 0 minutes over a 40 minute period. The ti ssues were 
then primed with 3µM of NE for I 0 minutes, and washed unti l they relaxed to baseline. All 
the tissues were equilibrated with cocaine (3µM) for 20 minutes to block uptake 1• This was 
followed by the administration of I OµM NE to determine the control response. After the 
response to NE had reached a plateau, the ti ssues were washed (five times) for at least 30 
minutes and allowed to stabilize at the baseline. Two of the four ti ssues were pretreated with 
3µM cocaine for 20 minutes. This was fo llowed by determining a E and tyramine 
concentration-response relationship for both agonists in the presence and absence of cocaine. 
After determining the control response, the response to NE in the presence of cocaine was 
approximately similar to the control response. It was then assumed that after the ti ssues had 
been repeatedly washed fo llowing the determination of the con tro l response, that cocaine did 
not remain in the tissue and a lter the response of the tissue to the subsequent experimental 
procedures. The response produced by each respective ago ni st conce ntration admini stered in 
the absence and presence of cocaine was analyzed for significant differences. 
The effect of endothelium removal on the norepinephrine response 
One ring was denuded by the careful rotation of a blunt toothpick inside the lumen of 
the vessel, while the endothelium of the other ring was left intact. After the equ ili bration 
period, the two ring segments were primed with 3µM NE for I 0 minutes and washed every 
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10 minutes for 40 minutes. This was fo llowed by the admi nistration of 120mM KCI. After 
obtaining a peak response to KC!, the ti ssues were washed and allowed to relax to baseline. 
The rings were pretreated with uptake and enzyme inhibitors, followed by the generation of a 
NE concentration-response relationship. The tissue's response to NE in the absence and 
presence of an endothelium was analyzed at their respective EC50 values. 
The effect of L-NAME on the norepinephrine response 
After the equilibration period, the two arterial ring segments were primed with 3µM 
E for 10 minutes and washed every 10 minutes for 40 minutes. This was followed by the 
administration of I 20mM KC!. After obtaining a peak response to KCl, the tissues were 
washed and allowed to relax to baseline. One tissue was pretreated with the nitric oxide 
synthase inhibitor, ro N-n itro-L-arginine methyl ester HCl (L-NAME; I OOµM), for 30 
minutes. All rings were pretreated with uptake and enzyme inhibitors, followed by the 
generation of a NE concentration-response relationship. The NE concentration-response 
curves were analyzed at their EC50 in the absence and presence of L-NAME. 
The effect of L-NAME on acetylcholine-mediated relaxation 
After the equilibration period, the two ring segments were primed with 3µM NE for 
10 minutes, and washed every I 0 minutes for 40 minutes. One ti ssue was pretreated with the 
nitric oxide synthase inhibitor, L-NAME (1 OOµM), for 30 minutes. Both tissues were 
initially contracted with 45mM KC! and allowed to stabi li ze at their maximum contractile 
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response. A cumulative acetylcholine concentration-response relationship (0.01 -1 OOµM) 
was superimposed over the KCl-induced contraction. The response produced by each 
incremental increase in concentration of acetylcholine, in the absence and presence of L-
NAME, was analyzed for s ignifi cant differences. 
Comparison of the contractile response to several agonists 
Contractile responses to epinephrine, angiotensin TI, 5-hydroxytryptamine (5-HT), 
medetomidine, B-HT 920, phenylephrine, and NE were evaluated using seven rings sectioned 
from the same artery segment. After equilibration, all the ti ssues were primed with 3µM NE 
for 10 minutes. The tissues were then washed and allowed to stabil ize for 30 minutes at 
baseline. T issues were then contracted with 120mM KCI. Fo llowing washout and relaxation 
to baseline, they were allowed to stabilize fo r 30 minutes before generating a cumulative 
concentration-response relationship to each agonist (0. 1 nM-1 OOµM). 
To maximize the agonist concentration at the receptor site tissues were pretreated, in the 
fo llowing way, with uptake and enzyme inhibitors. Tissue preparations for B-HT 920, 
epinephrine, phenylephrine, and NE were incubated with 0.36mM iproniazid for 60 minutes 
and then washed for 40 minutes . These four rings were pretreated with 1 µM propranolol for 
30 minutes to block P-adrenoceptors, and also pretreated with cocaine (3µM) and 
corticosterone (1 OµM) for 20 minutes to block uptake 1 and uptake2, respectively. Tissues for 
5-HT (serotonin) were pretreated with 3µM cocaine fo r 20 minutes before generating its 
concentration-response relationship. Tissues receivi ng medetomidine and angiotensin were 
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not equilibrated with uptake and enzyme inhibitors. The agon ist concentration-response 
curves were analyzed at their EC50 and maximum response. 
Evaluation of the response to isoproterenol 
Two tissue rings were sectioned from the same artery segment. After equilibration, 
the tissues were pretreated with the a-adrenoceptor antagonist, phentolamine ( 1 µM), for 45 
minutes. Tropolone (I OµM) and corticosterone (1 OµM) were added to the preparation for 20 
minutes to block COMT and uptake2, respectively. Both ti ssues were then contracted with 
45mM KCI and the response was allowed to stabilize. Cumulative add itions of isoproterenol 
(0.1-1 OOµM) were superimposed upon the KCl-induced contraction of one tissue preparation. 
The second tissue served as a control in order to monitor relaxation with time. 
The amount of relaxation, in both the time control and isoproterenol tissue 
preparations, was measured at the same point in time after each response to isoproterenol had 
stabi lized. This relaxation amount was expressed as a percent of the maximum response to 
45mM KCI in each tissue. The percent relaxation due to time was subtracted from the 
percent relaxation due to isoproterenol , thus obtaining the percent relaxation due to 
isoproterenol alone. 
The effect of propranolol on the response to isoproterenol 
During equilibration, the ring segments were incubated with the MAO inhibitor, 
0.36rnM iproniazid, for 60 minutes and washed every I 0 minutes for 40 minutes. Tissues 
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were then primed with 3µM NE for 10 minutes and washed unti l they stabilized at baseline . 
One tissue served as a control and received no antagonist. The other ti ssues were 
equilibrated wi th one concentration of propranolol (30nM, 1 OOnM, I µM) for 60 m inutes. All 
the ti ssues were pretreated w ith the nonselective a -adrenoccptor antagonist, phentolamine 
( I µM), for 60 minutes, and also pretreated with corticosterone (1 OµM) and tropolone (1 OµM) 
for 20 minutes to block uptake2 and COMT, respectively. All the tissues were then 
contracted w ith 45mM KC!, and the responses were allowed to stabilize. An isoproterenol 
concentration-response relationship (0.0 1-1 OOµM) was superimposed over the KCI-induced 
contraction. After the max imum response to I OOµM isoproterenol was obtained, 1 OµM 
sodium nitroprusside was added to the tissues in order to ascertain if the ti ssues were capable 
of fu rther relaxation. 
Determination of the dissociation constant (KA) for norcpinephrine 
After the equilibration period, ring segments were primed w ith 3µM NE for 10 
minutes and washed every 10 minutes for 40 minutes. Before generating a NE 
concentration-response relationship, the rings were pretreated w ith uptake and enzyme 
inhibitors, and also p roprano lol (0.3µM) for 60 minutes to block P-adrenoceptors. A 
cumulative concentration-response relationship was initially generated to NE. Following 
washout and stabilization at the baseline, dibenamine (0.3~LM for 20 minutes) , an irrevers ible 
a-antagonist, was then added to one of the ti ssue baths to inactivate a fraction of the a-
adrenoceptors. The other tissue served as a "time control tissue." After the dibenamine 
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treatment, the tissues were washed 4-5 times over a period o f 30 minutes. This was followed 
by determining a second NE concentrati on-response relationship. 
The methods and statistical analysis fo r determining the KA of NE follow those as 
described by Furchgott and Bursztyn ( 1967). After correcting for time-dependent changes in 
sensitiv ity, the NE concentration-response curves before ( l/[A]) and after ( l / [A']) 
dibenamine treatment were plotted. A double reciprocal plot of equi-effecti ve concentrations 
of NE before (1 /[A]) and after (1 /[A']) dibenamine treatment was made. This plot yields a 
slope of 1/q and an intercept of ( l-q)/q(K1J Using the slope and abscissa intercept, the KA 
and fraction of uninhibited receptors remaining, q, were calculated us ing the equation: l / [A] 
= 1-q/q[A'] + l/q(KA). In this equation the fraction of receptors remaining after dibenamine 
treatment, q, is equal to the rec iprocal of the slope. In simplifying thi s equation , KA= s lope-
! / intercept. To estimate the receptor reserve the fo llowing equation was used (Ruffo lo, 
1982): K A I EC50. 
Determination of dissociation constants (K8 ) for several antagonists 
Furchgott's ( 1972) methods were used to determine pA2 and KB va lues for the 
adrenoceptor antagonists, prazosin, phento lamine, rauwolscine, and idazoxan. The pA2 for 
prazosin was determined against the selective a 1-agonist, phenylephrine, and the 
nonselective a -adrcnoceptor agonist, NE. The pA2 for phentolan1ine and idazoxan were 
determined against E and phenylephrine, respectively. 
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After the equilibration period, the ring segments were primed with 3µM NE for l 0 
minutes and washed every I 0 minutes for 40 minutes. Before determining agonist 
concentration-response relationships, the rings were pretreated with uptake and enzyme 
inhibitors, and also propranolol (0.3µM) for 60 minutes to block ~-adrenoceptors. A control 
agonist concentration-response relationship was initially attained, and the tissues were 
washed until they stabi lized at baseline. One concentration of either prazosin (3nM, l OnM, 
30nM, 0.1 µM), phentolamine (30nM, 0.1 µM, 0.3µM, 1 µM), or idazoxan (3nM, I OnM, 
30nM, O.l~LM, 0.3µM, lµM), was then allowed to equilibrate for 60 minutes with each ti ssue 
before repeati ng the agonist concentration-response relationship. 
K8 and pA2 values were also determined for idazoxan, rauwolscine, and prazosin 
against the selective a 2-adrenoceptor agonist, medetomidine. After the equilibration period, 
ring segments were primed with 3µM NE for 10 minutes and washed every I 0 minutes for 40 
minutes. A concentration-response relationship to medetomidine was not generated before 
and after the tissue had equilibrated with the inhibitor (as was previously described using NE 
and phenylephrine) since medetomidine could not be washed out of the tissue after the 
determination of the control concentration-response relationship. Therefore, a control 
cumulative concentration-response relationship was determined to KCl (3- l 20mM) on all the 
tissues. The tissues were washed until they relaxed back to baseline. One tissue served as 
the control and received no antagonist. The other tissues were each equilibrated with one 
concentration of prazosin (3nM, l OnM, 30nM, 0. 1 µM, 0.3µM), rauwolscine (3nM, 30nM, 
O.lµM), or idazoxan (lOnM, 30nM, O.lµM, 0.3~tM, lµM) for 60 minutes. All the tissues 
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were pretreated with uptake and enzyme inhibitors, and a lso propranolol (0.3µM) for 60 
minutes to block P-adrenoceptors. This was followed by determining a medetomidine 
( I OnM-1 OOµM) concentration-response relationship. The response of each ti ssue to 
mcdetomidine was expressed as a percentage of its maximum response to KCI , and an EC50 
va lue was determined. Unfortunately, prazosin depressed the response to medetomidine 
below the EC50 value for the response to KC!. Therefore, the response to medctomidine was 
expressed as grams tension developed, not as a percentage o f the KCI response. 
The pA2 and K13 values were calculated according to Arunlakshana and Schild ( 1959), 
as described by Furchgott ( 1972), using the equation: log (DR- I) = log [B] - log K8 . The 
contractile response of each individual agonist concentration in the absence and presence of 
an antagonist was plotted to obtain the effective agonist concentrati on required to el ic it 50% 
of its maximal response (EC50) as indicated by Schild ( 1949). As was previously mentioned, 
the concentration ratio (CR) was calculated at the EC50 of the agonist concentration-response 
re lationship in the absence (A) and presence (A*) of each competiti ve antagonist 
concentration; whereby, CR = A*IA. After correcting for time-dependent changes in 
sensitivity, a Schild plot (Furchgott, 1972) of the log (CR- I ) against the -log of each 
antagonist concentration, [B] , was made to obtain the pA2 value (abscissa intercept) . If the 
blockage is competitive, the slope of the regression line should be unity. Under these 
dynamic conditions the pA2 = -log K13. 
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The effect of tone on the ti suc's respon e to medetomidine 
Three tissues were equilibrated for 90 minutes and then primed with 3µM NE for 10 
minutes. The tissues were washed (~ 30 minutes) until they stabilized at baseline. 120mM of 
KCI was administered and the response was allowed to reach its maximum before washing 
out. After the baseline had stabilized at 2g, NE (0.3µM) and phenylephrine (0.3µM -3µM) 
were added to one of the two tissues, respectively, to induce a small contracti le response just 
above threshold. The third tissue served as a control and received no agonist to induce tone. 
When the contractions had stabilized, a medetomidine cumulative concentration-response 
relationship was generated on all three ti ssues. 
Statistical analysis 
All results presented were corrected for sensitivity changes over time (see "Adjusting 
for sensitivity changes"). Results for each measurement arc presen ted as mean ± S.E. The 
number of different animals, n, for each experiment is indicated. Agonist EC50 values were 
calculated using least squares linear regression on the steepest part of the concentration-
response re lationship. Significant differences between two means were tested us ing the two-
tai led, paired or unpaired t-test (Eckblad, 1988; Netter et al., 1990). To test for signifi cant 
differences between means and variances when there were more than two groups, the one-
way analysis of vari ance (ANOVA) and F-max test were used, respectively (Eckblad, 1988; 
etter ct al., 1990). If the data was not normally di stributed or did not have an equality of 
variance, then a power transformation was used on the data before using ANOV A. When a 
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significant di ffe rence was detected using ANOV A, the a posteriori sum of squares 
simultaneous test procedure was used to make multiple compari sons between the different 
means (Eckblad, 1988). In the Schild plot, the t-test (null hypothesis is that s lope= unity) 
was used to determine if the slope was significantl y di fferent from unity (Eckblad, 1988). 
D ifferences were taken as significant when p<0.05. 
Drugs 
The fo llowing drugs were used: angiotensin II , (-)-epinephrine, (-)-i soprotereno l, (-)-
norepinephrine, cocaine, corticosterone 2 1-acetate, iproniazid, desipramine HCI, 5-
hydroxytrypta mine, sod ium nitroprusside, , co N-nitro-L-arginine methyl ester HC I (Sigma 
Chemical Co., t. Louis, MO); dibenamine I ICI (Smith, Kline, and French, Philadelphia, 
PA); medetomid ine HCI (Farmos Group Ltd., Turku, Finland); prazosin HC I (Pfizer Inc ., 
Brooklyn, NY); propranolol HCI (Ayerst Laboratori es, Inc., New York, N Y); tropolone 
(Aldrich Chemical Co., M ilwaukee, WI); tyrarnine (Calbiochem. , La Jolla, CA); 
phento lamine mesylate and rauwolsc ine HCI (Research Biochemicals lne., Natick, MA); 
phenylephrine HC I (Winthrop Laboratories, New York, NY); idazoxan (Kingston-Upon-
Hull , U.K.); B-HT 920 (Boehringer, lndelhe im, Germany). All drugs were disso lve in 9% 
saline except for corti costerone 2 1-acctate and dibenamine which were disso lved in ethanol. 
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CHAPTER 4. RESULTS 
Methodological considerations 
Several laboratories, including our laboratory (Zhang and Dyer, 1990), have stored 
fresh tissue overnight in a cold room to be reused the fo llowing day ( hibata et al., 197 I ; 
Langer et a l. , 1974). In our preliminary studies of the catecholamine disposition 
mechanisms, it was observed that ti ssue sensitivity significantly increased when tissues were 
co ld stored (4°C) for twenty-four hours (n=5). The maximum contracti le response prod uced 
by 30µM NE in fresh and cold stored tissues was 6.40 ± 0.62g and 9.5 I ± 0.64g, 
respecti vely (p<0.02). The response to E in the presence of the COMT inhibito r, tropo lone 
( IOµM; n=3), or the uptake, inhibitor, cocaine ( 1-IOOµM; n=3), differed between fresh and 
cold stored tissues. These inhibitors did not significantly potentiate the NE response in cold 
stored tissues. ince fresh and cold stored tissues differed in thei r response to E, only fresh 
ti ssues were used in subsequent experiments. This was similarly done by Nair and Dyer 
( 1974) using guinea-pig umbilical vessels. They found that the contractility of the um bi I ical 
vessels to serotonin, co ld stored (4°C) fo r more than four hours, differed from fresh tissue. 
The concentration-response curves to NE showed no sign ificant difference in potency 
and maximum response between the male and female median caudal arteries (n=6). The 
EC50 of male and female arteries was 5.28 ± 0.6 1 µMand 7.5 1±1 .77µM, respectively. The 
maximum response to 1 OµM NE on the median caudal artery from male and female bovine 
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was 6.92 ± 1.01 g and 7.86 ± 1.31 g, respectively. Since there was not a significant difference 
between male and female arteries in their response to NE, the arteries were not separated 
based on sex in subsequent experiments. 
Evaluation of the disposition mechanisms for norepinephrine 
The sensitivity of the tissue to NE is partially determined by the NE concentration 
within the neuromuscular junction and at the receptor site. A reduction in the NE 
concentration within the junctional cleft by the enzymatic (MAO and COMT) and uptake 
mechanisms (uptake1 and uptake2) may reduce the response of the tissue to NE. Inhibition of 
each of these disposition mechanisms should increase the response of the tissue to NE if that 
mechanism has an important role in the inactivation of NE within the neuromuscular 
junction. 
The enzymatic inactivation of norepinephrine was studied using iproniazid and 
tropolone, which are inhibitors for monoamine oxidase (MAO) and catechol-0 -
methyltransferase (COMT), respecti vely. Tropolone ( IOµM; n=5) significantly (p<0.01) 
shifted the EC50 of the NE concentration-response curve to the left approx imately 1.7-fold. 
However, there was no significant potentiation of the response to NE using 1 OOµM tropolone 
(n=5; Figure 4.1 ). No potentiation of the NE response was ascertained using 0.36mM 
iproniazid (n=6; Figure 4 .2). 
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Figure 4 .1. T he effect of tropo lone pretreatment (30 minutes) on the contractile response to 
norepinephrine. An asterisk(* ) indicates points on the curve (1x 10-5 M 
tropolone) wh ich are significantly different from the time control response. 
Each data po int represents the mean ± S.E. for 5 anima ls. 
39 
200% 
,.-.... 150% ---control ~ 0 
0 - - o - ·Time Control 0 
II • 0.36 mM lproniazid 
~ 
.,... 
0 
x 
100% -
µJ 
b 
Cl) 
Cl) 
c 
0 
0. 
Cl) 
Cl) 
o:'.'. 
~ 0 50% 
8 7 6 5 4 
-Log [Norepinephrine] (M) 
Figure 4.2. The effect of iproniazid pretreatment (60 minutes) on the contractile response to 
norep inephrine. Each data point represents the mean± S. E. fo r 6 an imals. 
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Extraneuronal uptake
2 
was evaluated using corticosterone 21-acetate (n=5). The NE 
concentration-response curve was shifted three-fold to the le ft using corticosterone 
concentrations of 1-1 OµM (p<0.02; Figure 4.3). The solvent for corticosterone, I 0µ1 ethanol , 
did not s ignificantly affect the EC50 for NE (n=5; Figure 4.4). 
Neuronal uptake
1 
was evaluated using the inhibitors, desipramine (n=5) and cocaine 
(n=6). Desipramine (0.3 nM-1 OµM) fa iled to potenti ate the response to NE. However, there 
was s ignificant inhibition (p<0.05) of the response to NE by I OµM desipramine, which 
shifted the NE EC
50 
to the right approximately fifteen-fo ld (Figure 4.5). Unlike desipramine, 
cocaine s ignificantly shifted the NE concentration-response curve to the left three- fo ld at 
concentrations of I OµM (p<0.00 I) and l OOµM (p<O.O I), however the potentiation by I µM 
cocaine was not s ignificant (Figure 4.6). Occasionally, coca ine at concentrations from 3-
l OOµM induced contracti ons. These experiments were exc luded from the study. Since 
1 OµM cocaine induced contractions more frequently than 3~LM cocaine, 3µM cocaine was 
used to block uptake 1 in subsequent experiments. 
The indirect agonist, tyramine, was used to investigate the importance o f the uptake1 
disposition mechanism. Tyramine acts through uptake1 to re lease NE from storage vesicles 
found within the prejunctional nerve terminal. Therefore, a tyramine- induced contraction 
indicates that stored NE is present in the nerve termina l. Blocking uptake 1 with cocaine 
should then decrease the amount of NE released by tyramine within the prejunctional nerve 
terminal (Furchgott, 1963). Cocaine (3µM) depressed the response to tyramine, but the 
magnitude of the effect was not sign ificant (n=4 ; Figure 4.7). Cocaine (3µM) was also found 
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Figure 4.3 . The effect of corticosterone pretreatment (30 minutes) on the contractile response 
to norepinephrine. Letters (a = Ix I o·6 M corticosterone, b = Ix I 0·5 M 
corti costerone) indicate points on the curves that are s ign ificantl y different from 
the time control response. Each po int represents the mean ± S.E. for 5 anima ls. 
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Figure 4.4. The effect of ethanol ( 10µ1) pretreatment (30 minutes) on the contractil e response 
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Figure 4.5. The effect of desipramine pretreatment (30 minutes) on the contractil e response 
to norepinephrine. An asterisk (*) indicates points on the curves that are 
significantly d ifferent from the time control response. Each data point represents 
the mean ± S. E. for 5 animals. 
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Figure 4.7. The concentration-response relationship for norepinephrine and tyramine in the 
presence and absence of 3~tM cocaine. A contro l response was initially 
determined to I OµM NE in the presence of 3 µM cocaine on all four tissues. 
Fo llowing washout, two o f the tissues were pretreated wi th 3µM cocaine (20 
minutes). This was fo llowed by the generation of a concentration-response 
relationship for both agonists in the presence and absence of cocaine. An 
asteri sk(*) indicates po ints on the curve that arc significantl y di ffcrent from the 
response to norepinephrine in the absence of cocaine. Each data point represents 
the mean ± .E. fo r 4 animals. 
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to significantly potentiate the response to NE (n=4). In these iproniazid treated tissues, 
tyramine elicited a max imum response that was 40% and 34% of the max imum response to 
NE in the absence and presence of cocaine, respectively . The experimental design of the 
present study assumed that the control response to NE, in the presence of cocaine, was 
completely washed out of the ti ssue before the subsequent procedures were carried out. 
There is a possibility that cocaine was not completely washed out of the tissue after the 
determination of the control response. However, the results do not suggest thi s since the 
control response was not significantly different from the response to E, in the presence 
cocaine, w hen determining the tyramine and NE concentration-response re lationships. 
The role of the endothelium in vasoactivity 
The endothelium was removed by rubbing the lumen of the tissues w ith a toothpick 
(n=4). This d id not significantly increase the max imum tension developed (g) to NE or shift 
the EC
50 
of the NE concentration-response curve to the left (Figure 4.8). Coincidentally, 
inhibiting the synthes is of NO with L-NAME also did not s ignificantly effect the maximum 
tension developed (g) to E or shift the EC
50 
of the NE concentrati on-response curve to the 
left (Figure 4.9). Acetylcholine relaxed arteries contracted by KC I ( 45mM), addition of 
sodium nitroprusside ( I O~tM) further relaxed the contraction by approx imate ly 15%. 
Pretreatment wi th L-NAME (I OOµM ; n=4) inhibited the acetylcholine-induced relaxation 
(Figure 4.10). 
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Figure 4.8 . The response to norepinephrine in the presence and absence of an endothe lium. 
To remove the endothelium, the lumen of the tissues were rubbed us ing a 
toothpick. A control response to 120 mM KCI was initially determined before 
generating a norepinephrine concentration-response relationship. Each data point 
represents the mean ± .E. for 4 animals. 
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Figure 4.9. The effect of L-NAME (lOOµM) pretreatment (30 minutes) on the contracti le 
response to norepinephrine. A control response to 120 mM KCI was initially 
determined on all tissues before generating a norepinephrine (NE) concentration-
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Figure 4 . 10. Relaxati on to acetylcholine in the absence and presence o f L-N AM E ( I OOµM) 
pretreatme nt (30 minutes). A ll tissues were initially contracted with 45mM KC I 
before determining the acetylcholine concentration-response relati onship. An 
asterisk (*) indicates po ints on the curve that are significantl y di fferent from the 
response to acetylcholine in the absence of L-NAME. Each data po int 
represents the mean ± S.E. fo r 4 animals. 
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Comparison of the contractile response to several agonists 
The maximum response and potency (EC
50
) produced by several agonists were 
compared. The max imum contractile response e licited by these agonists from highest to 
lowest was as fo llows: epinephrine > norepinephrine > serotonin > phenylephrine > 
angiotensin II > medetomidine (Table 4.1 ). The a
2
-adrenoceptor agonist, B-HT 920, fai led 
to produce a contraction (0.01 -1 OOµM). The potency of the various agonists was calculated 
at the EC
50 
of their respective concentration-response curves (F igure 4. 11 ). From highest to 
lowest, the order of potency was as fo llows: angiotensin II > serotonin > norepinephrine > 
medetomidine > epinephrine > phenylephrine (Table 4. 1 ). 
Determination of the dissociation constant (KA) fo r norepinephrine 
The fraction of a-adrenoceptors remaining, q, after irreversible a -adrenoceptor 
inactivation with dibenamine (O.J µM) was calculated from the slope of the double reciprocal 
plot of equi-effective concentrations of NE before and aft.er dibenamine treatment (n=5; 
Figu re 4.12). The ca lcu lated q value was 0.26, indicating 26% of the a -adrenoeeptors 
remained after dibenamine treatment. a-Adrenoceptor inactivation wi th dibenamine 
decreased the tissue response to NE by 64%. Several ti ssues contain an excess number of 
receptors which must be occupied in order to produce a maximum response. This excess of 
receptors above that needed to produce the maximum response const itute the receptor reserve 
(Ruffolo, 1982). 
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Table 4 .1. Comparison of agonist-induced contractile responses. 
Agonist pD2 (-Jog EC50) Maximum Response (o/o) 
Angiotensin IT 7.77 64 ± 16 
Serotonin 6.59 90 ± 16 
Norepinephrine 6.1 6 11 7 ± 24 
Medetomidine 5.61 46 ± 9 
Epinephrine 5.16 139± 34 
Phenylephrine 4.70 87 ± 15 
The maximum response is expressed as a percentage of the response to I 20mM KCI. 
The data are expressed as the mean ± .E. (n=S). 
B-HT 920 fa iled to produce a response (n=3). 
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200% 
Figure 4.11. Comparison of agonists to induce a contraction. A control response to 120 mM 
KCI was determined on all tissues before generating the agonist concentration-
response relationship. Each data point represents the mean ± S.E. for 5 
animals. 
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Figure 4.12. Determination of the dissociation constant for norepincphrine. (A) The 
contractil e response to norepinephrine before and after treatment (20 minutes) 
with 3µM dibenamine. (B) Double reciprocal plot of equi-effecti ve 
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The calculated NE dissociation constant (KA=3. I l µM) was higher than the NE EC50 
( I . I 4µM). The ratio of K/EC
50 
(2.73) indicated that an a.-adrcnoceptor reserve exists in the 
bovine median caudal artery. According to Ruffo lo (1982), the difference between the KA 
value and NE EC50 (as the K/EC50 becomes greater than 1) renects the existence and 
magnitude of the a.-adrenoceptor reserve. The percentage of adrenoceptors that need to be 
occupied to generate a half-maximal response was calculated using the ratio EC
50
/KA, which 
is equal to 0.37 (Ruffolo, 1982). It can be concluded that 3. 11 µM NE bound 50% of the a.-
adrenoceptors, but NE only needed to occupy 37% of the a.-adrenoceptors to achieve a half 
maximal response. This 37% receptor occupancy was achieved at 1. I 4µM NE. 
Determination of the dissociation constants (K8) for a.-adrenoccptor antagonists 
Phentolamine, the nonselecti ve a.-adrenoceptor antagonist, shi fted the NE 
concentration-response curve to the ri ght in a concentration-dependent fashion (n=6; Figure 
4.13). The slope (-1 .05) o f the Schild plot (Figure 4.14) was not significantly different from 
unity indicating that the antagonism by phentolamine was competiti ve. The calculated pA2 
and K8 values were 7.36 and 43.65nM, respectively. 
Prazosin , a selective a.
1
-adrenoccptor antagonist, shifted the NE concentration-
rcsponse curve to the right at concentrations of 3, 10, 30, and I OOnM (n=5; Figure 4 .15). 
When the data were subjected to Schild plot analysis (Figure 4.1 6), the s lope was -0.99 which 
55 
125% 
100% .--... - - • - ·Control -· '$. --o--- Time Control 
0 
- • - 3x I 0 -8 M Phentolamine 0 • -II --0-- lx lO -7 M Phentolamine ~ 75% 3x io-7 M Phcntolamine T/ / T / r . ,., • . 0 . - 0 Ix I 0 -6 M Ph en to lam ine >< '"' I -w I 6 r (l) 50% Vl c: 
0 
0. 
Vl 
I (l) ~ 
'$. 
25% . b . 
/ 
~ -0% • • . - - - 0 - 0 
8 7 6 5 4 
-Log [Norepinephr ine] (M) 
Figure 4 .13. The effect of phento lamine pretreatment (60 mi nutes) on the contractile 
response to norepinephrine. Each data point represents the mean ± S.E. fo r 6 
an ima ls. 
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Figure 4.14. Sch i Id plot for phentolaminc against norepincphrinc. C R represents a ratio at 
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50 
of norepinephrinc a fter and before antagonism by various 
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data was corrected fo r 
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(y = -I .05x + 7.76; r = 0 .95 ; pA
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= 7.36) . 
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Figure 4.15. The effect of prazosin pretreatment (60 minutes) on the contracti le response to 
norepinephrine. Each data point represents the mean ± S.E. for 5 animals. 
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Figure 4.16. child plot fo r prazosin against norepinephrine. CR represents a ratio at the 
EC50 of norepinephrine a fter and before antagonism by various prazos in 
concentrati ons (see Figure 4.15). The EC
50 
data was corrected for time-
dependent changes befo re being subjected to Schi ld plot analys is. Each data 
po int represents the mean CR ratio from 5 animals. The pA
2 
va lue for prazosin 
is represented by the abscissa intercept 
(y = -0.99x + 8.67; r = 0.95; pA
2 
= 8.74). 
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was not significantly different from unity. The calculated pA2 and K 13 values for prazosin 
against NE were 8.74 and 1.82nM, respectively. 
Prazosin was a very potent antagonist against the selective a
1
-adrenoceptor agonist, 
pbenylephrine (n=5). Incremental increases of prazosin (3-30nM) inhibited and gradually 
depressed the maximum response to phenylephrine (Figure 4. 17). The data were analyzed at 
the EC30 instead of the EC50 since the response to phenylephrine in the presence of prazosin 
did not always reach the 50% level. The contraction was almost completely inhibited by 
0. 1 µM prazosin (data not shown). The Schild plot (Figure 4. 18) yielded pA2 and K8 values 
of 9. 11 and 0.78nM, respectively; the slope (-0.83) was not significantly different from unity. 
Prazosin (3-30nM) depressed and shifted the concentration-response curves for the 
a 2-adrenoceptor agonist, medetomidine to the right. However, even though each animals' 
response to medetomidine was inhibi ted by prazosin, all the animals differed by a large 
magnitude in their response to medetomidine in both the presence and absence of prazosin. 
This large degree of variability caused the magnitudes to not be significantly different from 
the control response (n=6; Figure 4. 19). The selective a
2
-adrenoceptor antagonist, 
rauwolscine (3 nM-100nM), was evaluated against medetomidine (n=6). No inhibition was 
fo und (data not shown). The highly selecti ve a
2
-adrenoceptor antagonist, idazoxan (RX 
78 1094), did not alter responses to either medetomidine (Figure 4 .20) or phenylephrine 
(F igure 4.2 1 ). 
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Isoproterenol-mediated relaxation in the absence and presence of propranolol 
p
2
-Adrenoceptor-mediated tissue relaxation was studied using the P1- and P2-agonist, 
isoproterenol (n=5). Relaxation of the 45mM KCl-induced contraction was first observed at 
0.1 µM, and steadily increased with each half-log addition of isoproterenol (Figure 4.22). The 
maximum relaxation observed was I 0.3% by 1 OOµM isoproterenol. Isoproterenol-mediated 
relaxation of the KCl-induced contraction was not sign ificantly inhib ited by the P-antagonist, 
propranolol (n=5; Figure 4.23). 
The effect of tone upon the tissue's response to medetomidine 
A prccontractile stimulus (approximately 4-5% of the maximum response to KCI) by 
either NE or phenylephrine caused a decrease in the contracti le threshold for the selective a
2
-
adrenoceptor agonist, medetomidine, in four of the fi ve animals studied (1 animal failed to 
contract to medetomidine). The sensitivity to each concentration of medetomidine with tone 
was not significantly different from the control response. However, at lower medetomidine 
concentrations the probability of response homogeneity between the control and 
precontractile groups decreased (Table 4.2). The medetomidine percent response values have 
a high degree of error since all the tissues differed from one another by more than three 
standard deviations. In three of the fo ur tissues, precontraction with phenylephrine caused a 
greater response to low concentrations of medetomidine than precontraction with NE. 
66 
100% 
.. i· . . 
··+····1. 98% ,......_ 
';f?. 
0 96% 0 ' ' 
... f. ... II u 94% ~ --0--- Time Control 
::E - - • - · lsoproterenol * E ' 
'·!-'' l(') 92% ..q-'-" E * -... l ... :::s 90% E 
>< ~ 
~ 88% 
E * 0 
...'::: 
c 86% 0 
...... 
ell 
>< ell 
Q) 84% ~ 
';f?. 
* 82% 
80% 
8 7 6 5 4 
-Log (Isoproterenol] 
Figure 4.22. Relaxation of a KCl-induced (45mM) contraction by isoproterenol. An asterisk 
(*) indicates points on the curve that are significantly different from the time 
contro l response. Each data point represents the mean± S.E. for 5 animals. 
67 
100% 
. 'i . 
,-.._ 
'$.. ' 0 
0 ··i II 95% 
' 
u 
>---I ~ ~ -o--- Control 
V') 90% • • • • · 3x I 0 -S M Propranolol '<:t ...._, 
-o-- l x l 0-7M Propranolol E 
::I - a - 1 x IO -6M Propranolol E -- I x . . . 
Cl:S 
:E 85% 
E 
0 
r.J:l 
c:: 
.2 ....... 
Cl:S 
80% x 
Cl:S 
Q) 
~ 
'$.. 
75% 
8 8 6 5 4 
-Log [Isoproterenol] (M) 
Figure 4.23. Relaxation of a KCl-induced (45mM) contraction by isoproterenol in the 
absence and presence of various propranolol concentrations. Each data point 
represents the mean ± S.E. for 5 animals. 
68 
Table 4.2. Percent response (120 mM KC l = I 00%) to cumulative additions of 
medetomidine after an initial contraction to norepinephrine or phenylephrine. 
[Medetomidine]' 
(µM) 
Control 
Mean ± S.E.M . 
0.25%± 0.25 
0.50%± 0.50 
Norepinephrinc Phcnylephrine 
Mean ± S.E.M. Mean ± S.E.M. 
1.00%± 1.00 1.75% ± 1.75 
2.50%± 0.02 6.25%± 3.66 
0 .01 
0.03 
0.1 
0.3 
0.75%± 0.75 3.00%± 3.00 10.25%± 5.95 
b 
p = 0.08 
a 
3 
10 
30 
100 
1.00%± 1.00 
6.50%± 5.85 
27.50% ± 22.89 
41.00% ± 20.51 
50. 75% ± 22.28 
54.50% ± 20.85 
The data represents 4 animals. 
5.50% ± 4.56 13.75%± 8.25 
14.75%± 10.91 18.75%± 9.86 
19.75%± 14.55 23.75%± 14.48 
25.25% ± 16.7 1 30.50% ± 18.14 p = 0.14 
35.75% ± 19.38 34.00% ± 19.88 
41.50% ± 19.87 35.25%± 21. 12 
The mean of the response to medetomidinc differed by more than 3 standard deviations. 
There was no s ignificant difference in the response to individual concentrations of 
b 
medetomidine between all 3 groups (ANOY A, p > 0.05). 
Probability of response homogeneity between groups for medetomidine concentrations 
of 0.0 I µM to I µM (ANOV A). 
c 
Probability of response homogeneity between groups for medetomidine concentrations 
of3µM to lOOµM (ANOVA). 
c 
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CHAPTER 5. DISCUSSION 
Catecholamine disposition mechanisms 
The catecholamine concentration within the neuroeffector junction is regulated by 
several disposition mechanisms. Inhibition of these mechanisms should then increase the 
catecholamine concentration within the neuroeffector junction. Our premise stated that if the 
inhibited disposition mechanism plays a significant role in regulating the catecholamine 
concentration at the receptor site, then the sensitivity of the tissue to catecholamines would 
be expected to increase. 
Both cocaine and desipramine were used to block the uptake 1 (neuronal) 
catecholamine di sposition mechanism found within the prejuctional nerve terminal. Cocaine 
( I OµM and 1 OOµM) effectively potentiated the NE contractil e response, while desipramine 
(0.3nM-10µM) failed to lower the NE EC50 . The three-fo ld shift to the left of the NE EC50 by 
cocaine (1 OµM and 1 OOµM) demonstrates that the neuronal uptake mechanism is invo lved in 
catecholamine inactivation in the bovine median caudal artery. Other authors have reported 
similiar findings using relaxation and potentiation techniques (Trendelenburg, 1972, 
Guimaraes and Paiva, 1977; Kalsner and Nickerson, 1969; Shibata et al. , 1971 ). 
Investigators have reported that desipramine (0. 1 µM) potentiates the NE response to a lesser 
degree than cocaine ( l OµM) in both the rat anococcygeal muscle (Kenakin and Beek, 1981) 
and the isolated rabbit aorta (Auguet et al., 1982). In fact, higher concentrations of 
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desiprarnine (1 OµM) significantly inhibited the contractile response to NE in the present 
study. 
omogyi and Pere) (1991 ) reported that when strips from the rabbit atrium where 
preloaded with [3HlNE, high concentrations of desiprarni nc (50-1 OO~LM) inhibited the 
stimulation-induced release of [3II]NE, while low concentrations of dcsiprarn ine ($ I OµM) 
increased [3H]NE re lease from the neuron. The experimental methodo logy used by 
investigators suggests that higher concentrations of cocaine (30-1 OOµM) and desipramine 
(0.5-1 OµM) need to be used to increase the s imulation-induced release of ti ssue-loaded 
[3H]NE than is needed to potentiate the ti ssue response to NE when the amine is app lied to 
the organ bath (Purdy et al. , 1977; Hensling et al. , 1983 ; Somogyi and Percel, 199 1; Al-
Oamluj et al. , 1993; Kenakin and Beek, 198 1; Auguet et a l. , 1982). Therefore, 1 OµM 
desiprarnine may be capable of inhibiting the NE response in other ti ssues besides the bovine 
tail artery, while not inhibiting the re lease of [3 H]NE from preloaded tissues. These results 
suggest that despiramine's ability to potenti ate the NE response, by blocking uptake 1, is 
counteracted by some inhib itory mechanism. Somogyi and Perce I ( 199 1) suggested that high 
concentrations of desiprarnine may block the adrenergic neuron similiar to the actions of 
guanethidine. 
Cocaine caused periodic contractions in both fresh and cold stored tissues. This 
response has a lso been reported by other investigators (Egashi ra et al., 199 1; Webb and 
Vanhoutte, 1982; hibata et al. , 197 1; Furchgott et al., 1963). The mechanism behind 
cocaine- induced contractions is uncertain. Webb and Vanhoutte ( 1982), and Egashira et al. 
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( 1991 ) suggested that cocaine-induced contractions are caused by the presynapti c release of 
NE. This proposal contradicts Shibata et al. ( 197 1) who demonstrated that co ld storage 
drastically reduces the E content in the rabb it aorta, but does not reduce the cocaine-
induced potentiation of the NE response. Studies by Wyse ( 1974; 1976) demonstrated that if 
cocaine does exhibit postjunctional effects, its contribution in potentiating the catecholamine 
response is very small. Bevan and Verity ( 1967) also indicated that cocaine does not have 
postjunctional effects s ince when the nerve terminal s have degenerated, due to surgical 
sympathectomy, coca ine did not potenti ate the NE response. The influx of extracellular 
calcium may be invo lved in the cocaine-induced potentiation of the NE respo nse s ince a 
ca lcium-free media abo li shed the potentiation (Shibata et a l., 1971 ). Therefo re, cocaine-
induced potentiation o f responses to NE may involve calcium influx as well as inhibition of 
uptake1• This idea is strengthened by the fact that in the bovine ta il artery, gated calcium 
channels (not the sarcoplasmic reticulum) are the predominant means fo r increas ing the 
intracellular calcium concentration in the contraction process (Ashida et al. , 1988). Blocking 
ca lcium-dependent calcium channels decreased cocaine-induced potentiation of the response 
to NE (Suzuki et al., 1990). This suggests that the potentiation of the catecholamine response 
by cocaine is partia ll y due to calcium innux. 
Contractions to NE and tyramine in the presence and absence of cocaine confirmed 
the importance of uptake1 in regulating the catecholamine concentration at the receptor s ite . 
Tyramine acts th rough uptake 1 to release E from prejuncti onal storage vesicles. The 
released NE then induces a contraction by activating postjunctional a-adrenoceptors. 
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Cocaine interfered w ith tyramine's abi lity to release the neuronally stored NE by blocking 
uptake, (Furchgott ct a l. , 1963). Though not s ignificant, cocaine decreased the max imum 
response to tyraminc by 29%. This lack of significance is not unusua l since Furchgott et al. 
( 1963) reported that at high tyramine concentrations(> I OµM) cocaine demonstrates less 
abi li ty to inhibit uptake, since they compete for the same binding site. I le also indicated that 
to achieve an optima l inhibitory effect against tyramine, these drugs should be used in 
proportional concentrations. This was not done in the present study s ince a tyramine 
concentration relationship (0.0 1-l OOµM) was generated in the presence of3~tM cocaine. In 
the present study, cocaine a lso potentiated the response to NE. The maximum response 
elicited by tyramine, in the absence of cocaine, was approximately one-third of the maximal 
response to NE in the absence o f cocaine. These results compare favo rab ly with results 
obtained by other investigators who demonstrated that tyrami ne acts through uptake 1 to 
release presynaptically stored NE (Jo iner et al. , 1975; Auguet et al., 1982). 
Uptake2, found within the postjunctional cell, was studied using the uptake2 inhibitor, 
corticosterone 21-acetate. Corticosterone 21 -acetate effectively potentiated the NE response 
three- fold . A similar degree of potentiation, by inhibition of uptake2, has been demonstrated 
in the rabbit aorta (Henseling et al. , 1983; Martel et al. , 1993; Kalsner, 1975) and dog 
mesenteric artery (Guimaraes and Pa iva, 1977). Our results indicate that uptake2 is important 
in the catecholamine disposition process for the median caudal artery. 
Catechol-0-methyltransferase (COMT), primarily found within the effector cell, was 
studied using the COMT inhibitor, tropo lone (Verity et al. , 1972). A 1.7-fold potentiation of 
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the NE response (EC 50) by tropolone has been reported by other investigators (Levin and 
Furchgott, 1970; Guimaraes and Paiva, 1977; Wyse, 1974). It has been suggested that 
saturation of the COMT enzyme is possible (Kalsner and Nickerson, 1969; Graefe and 
Trendelenburg, 1974) since COMT has a lower Km than uptake2. (Henseling, 1980). Hence, 
at low concentrations of catecholamines, the rate of 0-methy lation serves as a good index for 
uptake2 activity s ince neither disposition mechanism is saturated (Martel ct al., 1993; Graefe 
and Trendelenburg, 1974). lt appears that in the bovine tail artery, the e ffector cell is 
significantly involved in the inactivation of catecholamines since both corticosterone and 
tropolone significantly potentiated the NE response. 
Monoamine oxidase (MAO) has little significance in the E degradation process, as 
evidenced by the lack of potentiation, when inactivated with iproniaz id . E lectron microscopy 
studies indicated a lack of mitochondria in the bovine tail artery (Ashida ct al. 1988). This 
may partially explai n the negl ig ible potentiation of responses to NE by inhibition or MAO. 
The fa ilure of iproniazid to potentiate the NE response agrees with studies done on the rabbit 
aorta (Ka lsner and Nickerson, 1969), guinea pig atria (Furchgott and Garcia, 1968), and the 
rat tail artery (Wyse, 1976). Neuronal uptake is not able to saturate MAO due to its high Km 
(Trendelenburg et al., 1987). I fowever, the rate of catecholamine accumulation with in 
storage granules may prevent potentiation with iproniazid (Furchgott and Garcia, 1968). 
Furchgott and Garcia ( 1968) found that inhibition of MAO did not potentiate the NE 
response in the guinea-pig atria. However, inhibition of MAO did increase the uptake of NE 
with in the nerve terminal to a greater degree than when MAO was not inhibited. This 
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suggests that even though inhibition of MAO did not potentiate the NE response, it may still 
be important in the inactivation of catecholamines. The rate o f ves icular neuronal uptake of 
catecholamines may be extremely high in the bovine tail artery, thus preventing potentiation 
of the NE response due to MAO inhibition. 
The concentration of catecholamines at the receptor site is predominantly determined 
by the density of adrenergic innervation, the thickness of the tissue, and the di stance between 
the prejunctional neuron and the effector cell (width of the neuromuscular junction). Since 
uptake1 is found prejunctionally on nerve terminals, the activity of uptake1 may serve as an 
approximation of the adrenergic innervation of a tissue (Trendelenburg, 1972). Therefore, 
the degree of cocaine-induced potentiation of the E response can serve as a rel ative index 
for the tissue's density of adrenergic innervation. However, if ti ssues differ by a large 
magnitude in their neuromuscular juncti on width or wall thickness, then inaccurate 
conclusions can be made about the extent of the tissue ' s adrenergic innervation. 
The magnitude of cocaine-induced potentiation of the NE response in the bovine 
median caudal artery is similar to the potcntiation induced by cocaine in less innervated 
tissues such as the rabbit aorta and dog mesenteric artery (Burnstock et a l. , 1972; Hirst and 
Edwards, 1989). Cocaine potentiated the NE response 2- to 3-fold in these tissues (Wyse, 
1974; Shibata et al. , 1971; Guimaraes and Paiva, 1977). The degree of potentiation is low 
when compared to more highly innervated ti ssues, such as the cat nictitating membrane, 
guinea-pig vas defercns, and cat spleen capsule (Merrillees ct al., 1963; Trendelenburg, 1972; 
Fillenz and Pollard , 1976; Van Orden, III ct al., 1967) . Cocaine potentiated the NE response 
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in the guinea-pig vas deferens 8- to 14-fo ld (Sannomiya and De Moraes, l 981; De Moraes 
and Capaz, 1977). In the cat spleen capsule and nictitating membrane cocaine potentiated the 
E response 20-fold, and 20- to 30-fold, respectively (Trendelenburg, 1972). This is in 
agreement with our premise, that the magnitude o f cocaine-induced potentiation serves as an 
index for the tissue's density of adrenergic innervation. ln thi s instance, the cat spleen 
capsule is less densely innervated that the cat nictitating membrane (Trendelenburg, 1972; 
Van Orden, III et al., 1967). Overall, on these highly innervated ti ssues, cocaine potentiated 
the NE response approximately 3 to 7 times greater than on the bovine tail artery. 
Trendelenburg ( 1972) hypothesized that the activity of uptake1 (and maybe the 
density of adrenergic innervation) is inversely proportional to the neuromuscu lar width 
distance. This was demonstrated in the nictitating membrane and vas deferens. These tissues 
are highly innervated and have a small neuromuscular junction width distance 
(Trendelenburg, 1972; ield and Zelcer, 1982; Merri llees ct al., 1963; Van Orden, 111 et al., 
1967). Our results suggest that the 3- fo ld potentiation of the NE response using cocaine may 
partially be due to a low density of adrenergic innervation for the bovine median caudal 
artery, and/or to a relatively wide neuromuscular junction width distance. 
After cold storage, the bovine median caudal artery's maximum response to NE 
significantly increased. This might be partially due to nerve degeneration, as was seen by 
annomiya and De Moraes (1979) when they denervated the gu inea-pig vas deferens 
(bil ateral postganglionic denervation). However, Langer ( 1974) hypothesized that the 
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increased response to NE was due to some unknown developmental change in the 
postj unctional cell brought on by the cold storage. 
The role of the endothelium in vasoactivity 
The endothe lium can influence vascular smooth muscle tone by re leasing the 
endothelium-derived vasodi lator, NO (Ignarro et al. , 1988). The literature contains 
documention that endothelium-denuded tissues are more sensitive to catecholamines than 
endothe lium-in tac t ti ssues (Oriowo et al. , 1987; Doggrell , 1992; MacLean et al. , 1993; 
Kaneko and Sunano, 1993). Our results tend to confi rm these reports, but the increase in 
sensitivity to NE on rubbed arteries was not significant. imilar to the rubbed arteries, 
pretreatment with L-NAME ( lOO~tM) did not significantly potentiate the response to NE. 
I lowever, L-NAM E did inhibit the acctylcholine-induced relaxation of endothe lium-intact 
arterial rings, indicating that the ti ssue is capable of synthesizing NO. The magnitude of 
acetylcholine-induced relaxation may be underestmiated since lgnarro et al. (1988) found that 
KCI inhibits acety lcholine-induced re laxation. Addition of sodium nitroprusside to a ti ssue 
exposed to acetylcholine (1 OOmM) caused an addi tional but small degree of relaxation. 
lgnarro et al. ( 1987; 1988) made similar observations using sodium nitropruss ide on the 
bovine intrapulmonary artery. Our results suggest that the endothelium contributes to the 
vasoactivity of the bovine median caudal artery. 
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Comparison of the contractile responses of several agonists 
A simple pharmacological way to determine the presence and to classify different 
receptor types is to compare the relative potencies of different agonists. However, the 
problem in using these comparisons is that ti ssues differ in their receptor density, efficacy, 
and affinity for each agonist (Drew, 1985). The order of potency fo r several agonists in the 
bovine median caudal artery from highest to lowest was as fo llows: angiotensin 11 > 
serotonin > norepinephrine > medetomidine > epinephrine > phenylephrine. B-HT 920 failed 
to produce a response. This demonstrates that besides a-adrenoceptors, angiotensin II and 
serotonin receptors (5-HT) may also contribute to the vasoactivity and tone of the artery. 
erotonin receptors (5-HT2) have been shown to be invo lved with vasoconstriction in the 
bovine uterine artery (Dyer, 1993), bovine coronary artery (Purdy and Milburn, 199 1 ), and in 
the isolated perfused bovine ear artery (Eghianruwa and Eyre, 1991 ). 
The selective aradrenoceptor agon ist, medetomidine, produced a contractile response 
at a lower concentration than that el ici ted by phenylephrine. However, medetomidine's 
potency was very low (p02=5.6 l ) when compared to its potency (pD2=9.0) on the mouse vas 
deferens (Virtanen et a l. , 1988). On the rat anococcygeus muscle, high medetomidine 
concentrations caused contractions that were inhibited by both prazosin and idazoxan 
(Scheinin et al. , 1989). These results suggest that medetomidine may act as a partial a 1- and 
ar agonist at high concentrations in the bovine tail artery. ince B-IIT 920 (se lective a 2-
agonist) fai led to produce a response, this indicates that a 2-adrenoceptors have e ither a low 
affi nity and/or efficacy, or that functional aradrenoceptors do not exist. 
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The pD2 for NE was 6.16, thi s is consistant with the potency fo r NE on the bovine 
dorsal pedal vein (pD2=6.25; Solomons et al., 1989) and the rat tai l artery (pD2=6.5; Oriowo 
et al., 1989) . The phenylephrine p02 for the bovine tail artery was 4.7. This is very low 
when compared to pD2 values on other ti ssues, such as the major arteries of the rabbit 
(pD2=5.5-6.7; Oriowo et al. , 1987), the bovine oviductal arteries (p0 2=5.93; Costa et al. , 
1992), and the rat aorta (pD2=7.27; Carrier and White, 1985). It may be that the a 1-
adrenoceptors have a low affinity/effi cacy fo r phenylephrinc. There is also a possibi li ty that 
a majority of the a-ad renoceptors are of the a 1A subtype since phenylephrine has a higher 
potency at the a JD subtype (Bylund, 1992). This is possible s ince the a 1A subtype displays a 
prominant ro le in the peripheral circulation of animals (Piasc ik et al. , 1994). 
Epinephrine was found to be less potent than NE. I rowever, our findings differ from 
studies done on other tissues. Epinephrine was found to be more potent than NE in both the 
rabbit aorta (Starke ct al. , 1975) and the rat caudal artery (Rajanayagam and Medgctt, 1987; 
Abel and Minneman, 1986). The d iffe rence in potency between epjnephrine and NE in thi s 
artery can not be expla ined by the presence of ~radrenoceptors since they were blocked by 
propranolol. Therefore, our data suggests that different a-adrenoceptor subtypes may exist 
with differences in their affini ty and/or efficacy fo r NE and ep inephrine. Since adu lt animals 
were used in this study, age might contri bute to the low potency of epinephrine (McAdams 
and Waterfall , 1986; Jagadeesh et al. , 1990) In the bovine aorta, the EC50 for epinephrine 
was 12-fold higher on aortas' from matu re than young animals, even though receptor density 
increased with maturity. It appears that the effi cacy of adrcnocepto rs decreases with age 
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(Jagadeesh et al. , 1990; McAdams and Waterfall , 1986). These results suggest that the 
efficacy of the a-adrenoceptors may be poor fo r initiating the response to epinephrine in the 
bovine tail artery. 
The adult bovine tail artery may also predominantly consist of low affinity a 1-
adrenoceptor binding s ites. A high and low affinity binding site fo r a 1-adrenoceptors has 
been proposed by many investigators based on the ability fo r competitive 
agon ists/antagonists to displace [3H]Prazosin from the a 1-adrenoceptor binding site (Morrow 
and Creese, 1986; Colucci et a l. , 1985; Jagadeesh and Oeth, 1987; Minneman, 1988). These 
two binding s ites appear to util ize different second messenger pathways for initiating the 
biological response (Jagadeesh and Deth, 1987; Jagadeesh et al. , 1990). The low affin ity site 
is less e fficient than the high affinity s ite in mediating a response, since its second messenger 
pathway operates independent from GTP-binding to the G-protein subunit. Jagadeesh et al. 
( 1990) reported an absence of the high affi nity site in the aorta of adult bovine. 
Jagadeesh and Deth ( 1987) found that in the aorta from young bovine, epinephrine 
was more potent at low affi nity s ites, while phenylephrine was more potent at the high 
affinity sites. If the bovine tail artery is primarily composed of low affinity sites, then it 
could be hypothesized that the concentration-response relationship would reveal a potency 
order of epinephrine greater than phenylephrine. This agrees with what was found for the 
bovine tail artery. This idea is further supported by the low p02 value for phenylephrine. 
Jagadeesh and Deth ( 1987) found that even though phenylephrine was more potent at the 
high affinity site than the low affi nity site, phenylephrine had a greater affi ni ty than both 
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epinephrine and NE for the low site. The difference between the potency and a ffinity of 
phenylephrine can be expla ined by the poor efficacy of the low site, as previously proposed 
by Jagadeesh and Deth ( 1987). Our hypothesis of a low a ffinity binding site does not 
correlate well with the method for classifying the a 1-adrenoceptor subtypes, as proposed by 
Morrow and Creese ( 1986), s ince phenylephrine has a low p02 value. Thei r classification 
method would label the high affinity s ite and low affinity s ite as being the a 1A and a 113 
subtype, respectively. However, it is possible that the efficacy of the a 113 subtype is very low 
for phenylephrine. The nomenclature and method for classifying a 1-adrenoceptor subtypes 
has been modified since Morrow and Creese c lassified a 1-adrenoceptors. a 1-Adrenoceptors 
are now divided into three subtypes: a 1A, a 18, and arn. It has been acknowledged that when 
pharmacologically c lassifiying a 1 subtypes, the results may display characteristics of both the 
a 1A and a 18 subtype. Therefore, it may not always be poss ible to clearly differentiate 
between the two subtypes (Hieble ct al., 1995). Data in the literature suggests that the high 
affinity site can be clearly identified as the a 1A-subtype, but the low affinity binding site 
exhibits characteristics that are different from both the arn and arn subtype (Piascik et al., 
1994). 
a 1-Adrenoceptors mediate the release of calcium from intracellular stores in a 
concentration-dependent manner (Awad et al., 1983; Colucci et al., 1985). This intrace llular 
calcium re lease is primarily responsible for the initial rapid phase of the contraction (Deth 
and Van Breemen, 1977; Ruffolo et al., 1991 ). Colucci et al. (1985) found that this is due to 
activation of the high affinity site. The bovine tail artery predominantl y increases its 
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intracellular calcium concentration by the inOux o f extracellular calcium since it lacks a 
sarcoplasmic reticulum (Ashida et al. , 1988; Goldman et al. , 1989). Therefore, the 
contractile response of the bovine tail artery to epinephrine may not be primarily mediated by 
the activation of the high affinity binding site. 
Our results suggest that the bovine tai l artery is predominantly composed of low 
affinity binding sites. However, properly classifying the binding s ites into subtypes can not 
be accurately done based on our studies. It does appear that more than one a 1-adrenoceptor 
binding site is present on this artery. 
Evaluation of the dissociation constant (KA) for norcpinephrine 
The percent of receptors occupied by an agonist is not usuall y proportional to the 
response it generates (Ruffo lo, 1982). To achieve a linear relationshi p, 50% of the receptors 
would need to be occupied to obtain a half-maxi mal response. The double reciprocal plot of 
NE, before and after dibenarnine treatment, indicated that 37% of the a -adrenoceptors needed 
to be occupied by N E to produce a half-maximal response in the bovine caudal artery. In the 
arteries supplying the bovine oviduct only 22% of the a-adrcnoceptors needed to be occupied 
(Costa et al., 1992), whi le in the rabbit aorta only 6% of the receptors needed to be occupied 
to produce a half-maximal response (Besse and Furchgott, 1976). Therefore, the bovine tail 
artery has a limited a-adrenoceptor reserve. The KA for NE on the bovine tai l artery 
(3. 1 I µM) was approximate ly similar to the K" (3.95µM) for the arteries supply ing the 
oviduct in the bovine (Costa et al., 1992). However, the NE KA for the bovine tai l artery is 
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somewhat higher than that reported for the rat tail artery (2 .5 1-2.9µM) (Oriowo et a l. , 1989; 
Abel and Minneman , 1986). 
The ratio of KA/ EC50 is an index for the receptor coupling e ffi ciency and recepto r 
reserve. The greater the KA/ EC50 ratio, the higher the e fficacy and receptor reserve for the 
tissue (Ruffo lo, 1982). The ratio o f 2.73 on the bovine median caudal artery was s imilar to 
the 2.86 ratio on the bovine oviductal arteries (Costa et al. , 1992). These ratios are low when 
compared to the ratio (7.9) fo r the rat tail artery (Oriowo et al. , 1989). I lowever, a ll three of 
these ratios are low when compared to the aorta of the cat, and the maj or arteries of the rabbit 
and rat (Oriowo et al. , 1987; Oriowo et al., 1989). This suggests that the bovine median 
caudal artery has a small a -adrenoceptor reserve and that the receptors have a low e ffi cacy 
for initiating the response to an agonist. It appears that NE has a slightly higher afiini ty fo r 
a -adrenoceptors in the bovine caudal artery than in the bovine oviductal artery, however the 
a -adrenoceptors o f the bovine tail rutery display a lower effi cacy fo r initiating a response to 
NE. Compared with the rat tail artery, the a -ad renoceptors of the bovi ne tail artery have both 
a lower affinity and efficacy for NE. Costa et al. ( l 992) proposed that when activated, 
bovine a -adrenoceptors may be inefficiently coupled to mechanisms which trigger the 
biological response. An inefficient coupling mechanism was also proposed by Jagadeesh and 
Deth ( 1987) fo r the low affini ty a 1-adrenoceptor si tes. 
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Evaluation of the dissociation constants (KB) for several antagonists 
The use of antagonists, instead of agonists, to distinquish between receptor types is 
useful because it measures the affinity of the antagonist fo r its receptor, and is independent of 
the agonist used (Arunlakshana and Schild, 1959; Drew, 1985). A competitive antagonist, 
acting against an agonist, will yield a pA2 value that is unique for a specific recep to r type 
(Arunlakshana and chi ld , 1959). The potent nonselectivc a -adrenoceptor antagonist, 
phentolamine, effecti vely shifted the NE concentration-response curve to the right. A Schild 
plot was used to calculate a pA2 value for phentolarnine. The pA2 value was 7.36, which is in 
close agreement with the literature values (pA2=7.48-7.8) for phentolamine acting on a -
adrenoceptors (Starke et al. 1975; Ennis and Cox, 1980). The slope (-1 .05) of the child plot 
did not differ from unity, indicating that the antagonism was competiti ve. The rat 
anococcygeus muscle, predominantly comprised of a 1-adrenoceptors, had a phento lamine 
pA2 value o f 7.70 (Drew and Whiting, 1979; Chapleo et a l. , 198 1 ). These results ind icate 
that phentolamine is acting on a population of a 1-adrenoceptors in the bovine tail artery. 
Prazosin, a selective a 1-antagonist, antagonized contractions induced by NE 
(nonselective a -adrenoceptor agonist) and phenylephrine (selective a 1-agonist). Calculated 
pA2 values fo r prazosin against NE and phenylephrine were 8. 74 and 9. 1 I, respectively. 
Prazosin 's antagonism was competitive against both agonists s ince the slopes of the chi ld 
plots were not significantly different from unity. 
On the bovine oviductal arteries (Costa et al. , 1992) and the rat caudal artery (Ori owo 
et al. , 1989), prazosin had a pA2 value of 9.38 and 8.8, respectively. Other investigators have 
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reported similiar prazosin pA2 values (7.9-9.8) on a variety of ti ssue types (Dunn et a l. , 199 1; 
Medgett and Langer, 1984; fsla and Dyer, 1990; Noguchi et al., 1993; Ennis and Cox, 1980; 
Agrawal et al. , 1984). At high concentrations of prazosin the maximum response to NE was 
depressed and thi s was also observed in the human omental vein (Steen et al. , 1984). The 
maximal contraction to phenylephrine was depressed by prazosin (10, 30, I OOnM). This 
reduction in phenylephrine's maximum response by prazosin was similarly observed in the 
rat tail artery ( avino and Varela, 1991) and rat aorta (Doggrell , 1992). 
Prazosin depressed and shirted the medetomidine cumulative concentration-response 
curves to the right. 1 lowever, the data were not analyzed by Schi ld plot analysis since 
prazosin (10-300nM) prevented medetomidine from generating a sigmoidal curve with a 
steep linear relationship. The selective a 2-adrenoceptor antagonist, idazoxan (3 nM-
1 OOOnM), did not affect the concentration-response curves for medetomidine or 
phenylephrine. Data in the literature suggests that idazoxan can discriminate between a 1-
and a 2-adrenoceptors, with the latter predominant! y antagonized at low ( I OnM) idazoxan 
concentrations (Medgett and Langer, 1984). The specific ity of idazoxan for a 2-
adrenoceptors was described by Chapleo et al. ( 1981) and Virtanen et a l. (I 988) in the rat vas 
deferens. Since prazosin, but not idazoxan, inhibited the response to medetomidine, this 
suggests that medetomidine is acting as a partial a 1-adrenoceptor agon ist in the bovine tail 
artery. This is supported by the fact that rauwolscine (3nM-1 OOnM), a selecti ve a 2-
adrenoceptor antagonist also failed to inhibit the medetomidinc-induced contraction. The 
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studies, using idazoxan and rauwolscine, suggest that the bovine tail artery lacks functiona l 
a rad renoceptors. 
The effect of tone upon the tissue's response to medetomidinc 
The literature suggests that postjunctional cxradrenoceptors can be revealed and 
expressed by increasing vessel tone (Dunn et al. , 199 1; Templeton et al., 1989; Furuta et al., 
1988). However, partiall y contracting the ti ssue with a low concentration of E or 
phenylephrine did not significantly increase the response of the artery to medctomidine. 
There did appear to be a greater increase in sensitivity, though not significant, between the 
control and precontratile groups at low medetomidine concentrations. By placing the vessel 
under tone we were not able to demonstrate that cxradrenoceptors ex ist in the bovine tail 
artery. Tissue responsiveness to concent ration-dependent increases of medetomidine varied 
considerably among all the arteries studied. Since Medgett and Langer (1986) hypothesized 
and demonstrated that the density of cxradrenoceptors differs among different strains ofrats, 
it may be that individual an imals possess thei r own unique density of cxradrenoceptors which 
maybe influenced by the animal's breed, sex, or sexual maturity. 
The evaluation of the response to isoproterenol in the absence and presence of 
propranolol 
A population of 13radrenoceptors appears to ex ist on the bovine tail artery since 
isoproterenol, in the presence of phentolamine, significantly relaxed arteries contracted to 
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KCI (45mM). However, isoproterenol only reduced the contraction by 10%. There is either 
a low density of Pr adrenoceptors, or the Pradrenoceptors have a low affin ity and/or 
efficacy for isoproterenol. Adenylyl cyclase can be inhibited or stimulated by ar and Pr 
adrenoceptors, respectively. Therfore, the ability for the bovine tail artery to activate 
adenylyl cyclase may be poor, or adenylyl cyclase may have an ineffiecent coupling 
mechanism for initiating it 's course of action since our results a lso support the absence of 
functional a r adrenoceptors (Rajanayagam and Medgett, 1987; McGrath, 1983). 
Propranolol (0.03- 1 µM) did not inhibit isoproterenol-mediated re laxation of the artery 
contracted to KCI. It may be that propranolol was not a llowed to equilibrate long enough in 
the bathing solution. However, thi s is unlikely since in the bovine coronary artery 
propranolol antagonized the isoproterenol-induced re laxati on after 30 minutes of 
equilibration time, and the Schild plot yielded a slope o f unity (Purdy and tupecky, 1986). 
A KCl-induced contraction may a lso not be the most appropriate agonist to use to study the 
effect of isoprotercnol. However, in the bovine intrapulmonary artery, there was no 
significant difference in the isoproterenol-induced relaxation between KCl- and 
phenylephrinc-precontracted rings ( lgnarro et al. , 1988). Coincidentially, Purdy and 
tupecky ( 1986) also used a KCl -induced contraction to successfull y calculate a pA2 (8.43) 
value fo r propranolol against isoproterenol in the bovine coronary artery. These results 
indicate that a small but inefficient population of P2-adrenoceptors ex ists on the bovine 
median caudal artery. There may a lso be a small population of Pr adrenoceptors on the 
artery, as was demonstrated in the canine cutaneous vasculature (Berl an et a l., 1994). 
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CHAPTER 6. SUMMARY 
Inhibitors of both the uptake 1 and uptake2 catecholamine di sposition mechanisms, and 
COMT, were effective in enhancing responses to NE. This suggests that uptake 1> uptake2 
and COMT are important in regulating the concentration of NE in the neuroeffector junction 
of the bovine median caudal artery. Monoamine ox.idase appears to have little importance in 
the regulation of catecholamines at the a-ad rcnoceptor site. I lowever, some uncertainties 
exist about the significance of the uptake 1 mechanism since cocaine, but not desipramine, 
potentiated the response to NE. Coicidentiall y, while cocaine potentiated the response to NE, 
cocaine a lso inhibited the response to tyramine. This suggests that the uptake 1 mechanism is 
intact and functional in the artery. Il igh concentrations of dcsipramine ( I OµM) actua lly 
inhibited the response to E. This suggests that desipramine 's ability to potentiate responses 
to NE may be counteracted by its inhibitory action. 
The importance of the endothelium in regulating vasoactivity is unclear. While 
inhibition of nitric oxide synthesis by L-NAME inhibited accty lcholinc-induced relaxation, 
L- AME did not significantly affect responses to NE, nor did removal of the endothelium. 
The artery may have a population of ~2-ad renoceptors that are capable of subserving a 
small degree of arterial relaxation. However, since the relaxation response to isoproterenol 
was not inhibited by proprano lol, proof of the presence and importance of ~2-adrenoceptors 
was not attained. 
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Agonist potency comparisons and the dissociation constants for phentolamine and 
prazosin suggest that a large functional population of a 1-adrenoceptors exists on the artery. 
However, the a-adrenoceptor reserve is limited. Thirty-seven percent of the receptors need 
to be occupied to produce a half-maximal response. As similarly concluded by Costa et al. 
(1992) on the bovine oviductal arteries, the a 1-adrenoceptors appear to have an inefficient 
coupling mechanism for contracting the bovine tail artery as revealed by the low KA/EC50 
ratio. Medetomidine generated a significant contraction that was inhibited by prazosin, but 
not by idazoxan or rauwolscine. However, the a 2-adrenoceptor population may not be 
functional since B-HT 920 did not generate a contraction. Medetomidine also had a low p02 
value which was not significantly increased when the artery was put under tone. Therefore, 
medetomidine appears to act as a partial a 1-adrenoceptor agonist. This suggests that the 
bovine median caudal artery lacks functional aradrenoceptors. 
Some additional studies need to be done in the future. We feel that our agonist 
comparison contractile results are valid. However, since the response of the tissue to 
epinephrine contrasts a majority of the literature data, this experimental study needs to be 
repeated. There is still some uncertainty concerning the existance of the aradrenoceptor 
population. Therefore, further experiments in attempting to "uncover" their presence are 
needed. Perhaps placing vessels under tone with other agonists, such as angiotensin II , 
vasopressin, serotonin, or endothelin may prove fruitful. The functional significance of the 
P2-adrenoceptor population needs to be ascertained using some additional agonists to induce 
tone. Since only a KCl-induced contraction was used to study isoproterenol-induced 
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relaxation, perhaps vasopression, angiotensin II , prostaglandin F2a , or phenylephrine should 
by used to induce tone. Of course, blockade of the isoproterenol response by a P2-antagonist, 
such as propranolo l, wi ll be needed to convicc the scientific community of the presence and 
activity of Pradrenoceptors in the median caudal artery. Further experiments using 
radioligand binding techniques will greatly assist the pharmacological classification of 
adrenoceptors in this artery. 
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